* * * * * * * * * * * * * * *

STEPHANIE ROSCOE, as * PUBLISHED

Representative of the Estate of *

B.R., deceased, * No. 11-206V

*

Petitioner, * Special Master Nora Beth Dorsey

*

v. *

* Entitlement; Hepatitis A (“Hep A”)

SECRETARY OF HEALTH * Vaccine; Tetanus-Diphtheria-Acellular

AND HUMAN SERVICES, * Pertussis (“Tdap”) Vaccine; Meningococcal

* (“Menactra”) Vaccine; Human

Respondent. * Papillomavirus (“HPV”) Vaccine;

* Streptococcus Pyogenes; Death.

* * * * * * * * * * * * * * *

Richard Gage, Richard Gage, P.C., Cheyenne, WY, for petitioner. 

Kyle Edward Pozza, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT1

I. INTRODUCTION

On April 4, 2011, Stephanie Roscoe (“petitioner”), as representative of the estate of B.R., 

deceased, filed a petition under the National Vaccine Injury Compensation Program (“Vaccine 

Act” or “the Program”), 42 U.S.C. § 300aa-10 et seq. (2012).

2 Petitioner alleges that as a result 

1 Because this Ruling contains a reasoned explanation for the action in this case, the undersigned 

is required to post it on the United States Court of Federal Claims’ website in accordance with 

the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and 

Promotion of Electronic Government Services). This means the Ruling will be available to 

anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 

days to identify and move to redact medical or other information, the disclosure of which would 

constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the 

identified material fits within this definition, the undersigned will redact such material from 

public access.

2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National 

Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 

42 U.S.C. §§ 300aa-10 to -34 (2012). All citations in this Ruling to individual sections of the 

Vaccine Act are to 42 U.S.C. § 300aa.

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

Filed: June 8, 2020 
2

petitioner is entitled to compensation.

II. ISSUES IN AGREEMENT AND IN DISPUTE

The parties agree that B.R.’s death was “most likely caused by a gram-positive bacteria,

Streptococcus pyogenes [], that resulted in an infection in her hip, which led to septic shock that 

ultimately caused her death.” Resp. Submission, filed Dec. 20, 2019, at 4 (ECF No. 166); accord

Petitioner’s (“Pet.”) Submission, filed Dec. 23, 2019, at 2 (ECF No. 167). They generally agree 

that there is a factual issue as to whether B.R. had a sore throat prior to her vaccinations, and if 

so, the medical significance of her sore throat. Resp. Submission at 4; Pet. Submission at 2. 

This issue will be addressed as part of the causation analysis related to Althen Prong Two. 

The issue in dispute is whether petitioner has established by preponderant evidence that 

B.R.’s vaccinations administered on March 31, 2009 were a substantial factor in causing her

death.

III. BACKGROUND

A. Procedural History

This case has a long and complicated procedural history. Petitioner filed her claim on 

April 4, 2011, and subsequently filed medical records and an expert report. See Petitioner’s 

Exhibits (“Pet. Exs.”) 1-6. On November 18, 2011, respondent filed his Rule 4(c) Report, in 

which he recommended against compensation. Resp. Rept. at 2. Respondent maintained that 

petitioner failed to provide a “sound and reliable” medical theory that supports the claim that 

B.R. was injured and died as a result of the vaccinations. Id. at 11.

3

Streptococcus pyogenes is “a ß-hemolytic species [of Streptococcus] that comprises group A of 

the Lancefield classification and is toxigenic and pyrogenic.” Streptococcus Pyogenes,

Dorland’s Med. Dictionary Online, https://www.dorlandsonline.com/dorland/definition?

id=108772 (last visited May 27, 2020). Throughout this Ruling, Streptococcus pyogenes may be 

abbreviated as S. pyogenes or simply as strep.

of receiving hepatitis A (“Hep A”), tetanus-diphtheria-acellular pertussis (“Tdap”), 

meningococcal (“Menactra”), and human papillomavirus (“HPV”) vaccines on March 31, 2009, 

B.R. suffered fever, leg and bodily pain, emotional and mental confusion and anguish, and death. 

Petition at 1 (ECF No. 1). Respondent argued against compensation, stating that “this case is not 

appropriate for compensation under the terms of the Vaccine Act.” Respondent’s Report (“Resp. 

Rept.”) at 2 (ECF No. 16).

After carefully analyzing and weighing the evidence presented in this case in accordance 

with the applicable legal standards, the undersigned finds that petitioner provided preponderant 

evidence that one or more of the vaccines B.R. received caused her to develop a Streptococcus 

pyogenes3infection that caused her death, which satisfies her burden of proof under Althen v. 

Secretary of Health & Human Services, 418 F.3d 1274, 1280 (Fed. Cir. 2005). Accordingly, 
3

4 The Vaccine Act provides, “[i]f a plaintiff has pending a civil action for a vaccine-related 

injury or death, such person may not file a petition under [the Vaccine Act] for such injury or 

death.” § 11(a)(5)(B). It also provides that if “a civil action brought against a vaccine 

administrator or manufacturer for a vaccine-related injury or death” results in an award of 

damages “under a judgment of a court or a settlement of such action, the person who brought 

such action may not file a petition under [the Vaccine Act] for such injury or death.” § 11(a)(7).

On January 5, 2012, petitioner was ordered to file a supplemental expert report to address 

the issues raised in respondent’s Rule 4(c) Report. Order dated Jan. 5, 2012, at 1 (ECF No. 18). 

Petitioner sought and was granted several extensions of time within which to file the 

supplemental expert report, which was ultimately filed on January 15, 2013. Supplemental 

(“Suppl.”) Expert Rept., filed Jan. 15, 2013 (ECF No. 26). Respondent filed an expert report on 

April 10, 2013. Resp. Ex. A. An entitlement hearing was scheduled for November 19 through 

21, 2013. Prehearing (“Prehr’g”) Order dated May 14, 2013, at 1 (ECF No. 32). During summer 

2013, the parties engaged in settlement negotiations, and on August 22, 2013, the case was 

referred to Special Master Moran for alternate dispute resolution (“ADR”) proceedings. Order 

dated Aug. 22, 2013, at 2 (ECF No. 38). The case did not proceed to hearing but remained in 

ADR until February 2014, at which time a 15-Week Stipulation Order was entered and an order 

removing the case from ADR was issued. See 15-Week Stipulation Order dated Feb. 4, 2014 

(ECF No. 44); Order dated Feb. 6, 2014 (ECF No. 45). 

On July 8, 2014, a status conference was held by the presiding special master to discuss 

petitioner’s counsel’s concerns about the stipulation. Order dated July 8, 2014, at 1 (ECF No. 

47). Petitioner’s counsel reported that petitioner may have received a settlement for B.R.’s 

injury and death.4Id. Petitioner had been instructed not to disclose information about the 

settlement and the implications on the agreed upon stipulation related to the present claim. Id. 

Petitioner’s counsel was instructed to obtain more information. Id. 

On July 18, 2014, petitioner filed a copy of the complaint she filed in the State Court of 

Dougherty County, State of Georgia, on April 1, 2011, against a number of individually named 

physicians, their employers, and Phoebe Putney Memorial Hospital (“Phoebe Putney”) for 

medical negligence and the wrongful death of B.R. Response to Court Order, filed July 18, 

2014, at 2-20 (ECF No. 49). Petitioner also filed an amended complaint, which included 

affidavits of Dr. George Jerome Shaw, III and Dr. Robert Mills, setting forth alleged negligent 

acts committed by the physicians and nursing staff at Phoebe Putney. Id. at 21-36. Neither the 

complaint or the amended complaint state any allegations based on the vaccines, against the 

person who administered the vaccines, or the manufactures of the vaccines. Subsequently, 

discovery depositions from petitioner’s Georgia civil case were filed. (ECF Nos. 55, 58-60). 

On July 21, 2014, the special master issued an Order to Show Cause why the case should 

not be dismissed because the petitioner had a pending civil action when she filed her petition in 

this Court. Order dated Sept. 25, 2014, at 3 (ECF No. 54). The issue was briefed, and the parties 

agreed that the controlling case was Schumacher v. Secretary of Health & Human Services, 2 

F.3d 1128 (Fed. Cir. 1993). Id. (citing Pet. Brief in Support of Mutual Agreed upon Stipulation

Approval and Opposition to Dismissal, filed Aug. 22, 2014, at 3-4 (ECF No. 52); Resp. Reply to

Pet. Response to the Order to Show Cause and Motion to Strike, filed Sept. 25, 2014, at 4 (ECF
4

No. 53)). In Schumacher, the Federal Circuit held that the Vaccine Act does not bar a petitioner 

from filing a vaccine petition when her pending civil action is not against a vaccine manufacturer 

or vaccine administrator. Id.; Schumacher, 2 F.3d at 1133. Thus, the special master issued an 

order in which she ruled that the Vaccine Act did not require dismissal of the petition in this 

Court. Order dated Sept. 25, 2014, at 3. Respondent was given time to review new evidence, 

particularly the deposition testimony of the physicians who provided care to B.R. as well as the 

experts who gave testimony in the State Court civil action in Georgia, and to reevaluate his 

position as to the settlement agreement. Id. at 4. After review of the new evidence, respondent 

withdrew the settlement offer and wished to proceed with litigation. Order dated Feb. 20, 2015 

(ECF No. 62).

The special master then reviewed the evidence, and issued an order providing her 

impressions of the evidence. See Order dated Mar. 25, 2015, at 2-8 (ECF No. 63). She listed 

several options for the parties to take: (1) petitioner can provide pathology slides to the 

respondent’s expert for review; (2) the parties can consider revisiting mediation; and (3) if the 

parties could not informally resolve the case through settlement, they can proceed to a hearing. 

Id. at 8. The parties did not revisit mediation. Petitioner was ordered to file medical literature, 

locate or file the culture results for B.R., and exchange the autopsy slides so that experts for both 

parties could review them. Order dated Mar. 26, 2015, at 1 (ECF No. 64). Petitioner filed a 

supplemental expert report by Dr. Harry S. Latham, and respondent filed a supplemental expert 

report by Dr. Sara Vargas. (ECF Nos. 67, 69). 

The case was assigned to the undersigned on February 4, 2016, and an entitlement 

hearing was set for March 15 and 16, 2017. Notice of Reassignment dated Feb. 4, 2016 (ECF 

No. 77); Prehr’g Order dated Mar. 22, 2016 (ECF No. 81). On January 17, 2017, the 

undersigned held a status conference to advise the parties that due to the continuing resolution, 

the Office of Special Masters did not receive its full budgetary allotment for 2017, and therefore, 

special masters did not have funds to travel for hearings. Order dated Jan. 18, 2017, at 1 (ECF 

No. 82). Petitioner requested that the hearing be rescheduled once the continuing resolution had 

ended, and requested that the hearing be held in Albany, Georgia so that petitioner and B.R.’s 

family could attend. Id. Alternative hearing dates in June and August 2017 were discussed and 

provided to the parties. Id. The hearing was rescheduled for June 6 and 7, 2017. Prehr’g Order 

dated Feb. 3, 2017 (ECF No. 84). The parties filed their respective pre-hearing submissions, and 

additional documents including medical literature. 

On June 2, 2017, petitioner’s counsel contacted the undersigned to request that the 

hearing set for June 6 and 7, 2017 be rescheduled due to petitioner’s counsel’s medical 

emergency. Order dated June 5, 2017 (ECF No. 100). The entitlement hearing was cancelled 

and rescheduled for January 8 and 9, 2018. Id.; order dated Sept. 25, 2017 (ECF No. 106). At 

the pre-hearing status conference on December 19, 2017, counsel for petitioner advised that he 

required further hospitalization due to his medical condition, and therefore, the hearing was 

again postponed and rescheduled for May 21 and 22, 2018. Order dated Dec. 19, 2017 (ECF No. 

109); order dated Jan. 31, 2018 (ECF No. 113). Petitioner’s counsel was asked to consider 

associating with co-counsel. Order dated Dec. 19, 2017, at 1; order dated Jan. 31, 2018, at 1. 

Subsequently, the hearing set for May 2018 was cancelled to allow petitioner’s counsel to 

associate counsel. Order dated Feb. 13, 2018 (ECF No. 115). 
5

This matter is now ripe for adjudication.

B. Summary of Relevant Facts

1. Medical Records

B.R. was born on September 4, 1997. Pet. Ex. 14 at 1. Prior to the March 31, 2009 

vaccinations, she had no prior significant illnesses, no previous surgeries, and no hospitalizations 

since birth. Id. She did have the Sickle Cell Trait. Id. 

On March 31, 2009, B.R. presented to her pediatrician’s office for her 11-year well-child 

visit. Pet. Ex. 14 at 3. She had no new complaints. Id. Her records show that she had no known 

drug allergies. Id. She was afebrile, pulse 90 and regular, and respiratory rate 22. Id. She was 

5 For the sake of accuracy and consistency, this Ruling refers to petitioner instead of petitioners 

throughout, reflecting that Stephanie Roscoe is the current and proper petitioner, although the 

petition was originally filed by both Frederick Parks and Stephanie Roscoe. 

On June 25, 2018, petitioner filed a motion to substitute counsel for Attorney Richard 

Gage. Motion to Substitute Attorney, filed June 25, 2018 (ECF No. 121). The motion was 

granted and a status conference was held on July 12, 2018 with new counsel. Order dated July 

13, 2018 (ECF No. 122). Petitioner requested the opportunity to obtain an additional expert, 

which was granted, and petitioner was ordered to file the expert report by September 11, 2018. 

Id. at 1-2. The medical records and other exhibits were refiled in proper format. See Pet. Exs. 

12-41. A Vaccine Adverse Event Reporting System (“VAERS”) report was also filed. Pet. Ex.

42. After several motions for extension of time were requested and granted, petitioner filed the

expert report of Dr. Douglas Miller on March 12, 2019. Pet. Ex. 43. Respondent filed his

responsive report on July 15, 2019. Resp. Ex. Z.

On December 24, 2019, petitioner filed a motion to amend the case caption to remove the 

name of Frederick Parks as a petitioner. Motion to Amend Caption, filed Dec. 24, 2019 (ECF 

No. 168). Letters of Administration dated October 4, 2013, naming Stephanie Michelle Roscoe 

as Administrator of the estate of B.R., were also filed. Pet. Ex. 45. The motion amending the 

case caption was granted on January 3, 2020.5 Order dated Jan. 3, 2020 (ECF No. 171). 

An entitlement hearing was finally held on January 8, 2020 in Atlanta, Georgia. The 

petitioner attended the hearing but did not testify. See Transcript (“Tr.”) 3-4. Petitioner’s 

expert, Dr. Miller, and respondent’s expert, Dr. Vargas, testified. Tr. 3. After the hearing, 

respondent requested the opportunity to brief the deposition testimony of physicians who 

testified in petitioner’s civil action, including Dr. Latham, Dr. Mills, Dr. Mark Noel Burns, and 

Dr. Belise Livingston-Burns, as well as address additional matters that arose during the hearing. 

Resp. Status Rept., filed Jan. 22, 2020, at 1-2 (ECF No. 175). Respondent’s request was granted. 

Order dated Jan. 22, 2020 (ECF No. 176). Respondent’s post-hearing brief was filed on 

February 24, 2020, and petitioner filed her post-hearing brief on March 9, 2020. Resp. Posthearing Brief (“Posthr’g Br.”), filed Feb. 24, 2020 (ECF No. 181); Pet. Posthr’g Br., filed Mar. 9, 

2020 (ECF No. 182). 
6

five feet and three inches tall and weighed 149 pounds. Id. Her BMI was 26.39. Id. Urine dip 

stick analysis was normal and hemoglobin was normal at 11.8. Id. B.R. received the Hep A and 

HPV vaccines in her upper right arm and the Tdap and Menactra vaccines in her upper left arm. 

Id. at 4. 

On the following day, April 1, 2009, at 5:45 PM, B.R. was admitted to Phoebe Putney 

Emergency Department (“ED”) with complaints of hip pain and fever. Pet. Ex. 14 at 10. Triage 

assessment performed at 6:00 PM revealed that B.R. had a fever of 102.9°F, pulse of 115 per 

minute, and pain level of 10/10. Id. She was noted to have been febrile with poor oral intake. 

Id. B.R.’s pain began at 3:30 AM, and was described as “affecting [her] left iliac crest and 

pelvis.” Id. at 11. A history was obtained from B.R.’s mother, petitioner. Id. B.R. had no 

history of cough, sore throat, runny nose, or ear pain. Id. Prior to her arrival, she had “been 

playful and normally active.” Id. She did have history of fever for the last few hours, with a 

maximum temperature of 102 to 103, without chills or sweats. Id. She had no nausea, vomiting, 

or diarrhea. Id. 

A physical examination was performed by Dr. Alfred L. Woodard. Pet. Ex. 14 at 12. 

B.R.’s neck was supple with “[n]o significant adenopathy.” Id. Her throat was clear with no

evidence of inflammation. Id. Her tympanic membranes were clear and there were no signs or

symptoms of otitis media (i.e. ear infection). Id. There was no anterior or posterior

lymphadenopathy. Id. She had unlabored respirations with good breath sounds, and “[n]o

audible rales, ronchi [sic], or wheezing.” Id. She did not cough or have wheezing during the

examination, and she had no respiratory distress. Id. B.R. was “[m]oderately tender to palpation

over the left anterior thigh” and her skin was “clear with no lesions or rash.” Id. Diagnosis was

fever and pediatric viral syndrome. Id. B.R. was given acetaminophen and ibuprofen. Id.

Laboratory tests were performed including a complete blood count (“CBC”) with differential,

urinalysis, and urine culture. Id. at 13. The differential portion of B.R.’s CBC was abnormal,

with lymphocytes low at 13.1% (normal 26.0-40.0) and monocytes elevated at 12.6% (normal

1.0-9.0). Id. B.R.’s urinalysis was normal. Id. The results of the urine culture were not

reported back before B.R.’s discharge from the ED, but subsequently the report showed less than

100,000 morphotype bacteria with no predominant organism. Id. at 18.

B.R. was discharged from the ED at 8:47 PM by Dr. Woodard. Pet. Ex. 14 at 14. Her 

temperature at the time of discharge remained abnormal and her mother was advised to followup with her pediatrician if B.R.’s symptoms worsened. Id. B.R.’s pain at the time of discharge 

was 2/10. Id. 

At 8:04 AM on April 3, 2009, B.R. was taken by her parents to the Palmyra Medical 

Center (“Palmyra”) Emergency Room (“ER”) for fever and pain in the left thigh, with nausea 

and vomiting, and a rash. Pet. Ex. 14 at 120. An “Emergency Room Patient Sign-in Sheet 

Patient Information” form was completed and stated that B.R. had a “[h]igh fever since 

Tues[day]. Extreme upper thigh pain. She had 4 vaccines on Tues[day]. Gagging Dehydrated.” 

Id. at 133. On the form’s list of signs and symptoms, B.R. was noted to have fever and fatigue. 

Id. She did not have a cough, shortness of breath, or close contact with a person who had 

respiratory symptoms. Id.
7

6 This report was interpreted as a contaminated specimen and not infection. See Tr. 56; Pet. Ex. 

13 at 24.

7 Dr. Livingston’s history and physical examination was dictated on April 3, 2009, at 10:19 PM, 

and transcribed April 4, 2009, at 10:39 AM. Pet. Ex. 14 at 30. 

An initial assessment was performed at 8:20 AM. Pet. Ex. at 120. B.R. was noted to be 

in mild distress, with an elevated heart rate of 147 and elevated temperature of 102.7 F. Id. Her 

pain level was 6/10 and her pain was described as aching. Id. She had no respiratory distress 

and breath sounds were normal. Id. She was seen by Dr. David L. Kocherla who noted a rash on 

B.R.’s neck. Pet. Ex. 13 at 17. He ordered blood and urine cultures, urinalysis, other laboratory

studies, intravenous fluids, and a portable chest X-ray. Pet. Ex. 14 at 122. The urine culture

showed “[m]ixed urogenital flora” with no growth of a significant single organism.6 Pet. Ex. 13

at 24. The chest X-ray impression was “[n]o evidence of frank pneumonia,” but “bronchitis or

atypical pneumonia” could not be excluded. Id. at 27. Motrin, Tylenol #3 and Zofran were

administered. Pet. Ex. 14 at 121. Dr. Kocherla’s diagnosis was post-vaccination reaction. Id. at

139. At 1:00 PM, Dr. Kocherla ordered that B.R. be transferred to Phoebe Putney for admission.

Id.

B.R. was transported from Palmyra to Phoebe Putney by ambulance. Pet. Ex. 14 at 35. 

The ambulance trip report states B.R. “is being transferred . . . for follow up care . . . for a 

possible allergic reaction to immunizations administered on 03/31/2009,” and “[B.R.] [complains 

of] left hip pain,” which she describes “as sharp and non radiating” and “[r]ates pain as 10 on 1-

10 scale.” Id. 

After arrival at Phoebe Putney, B.R. was seen by admitting physician, Dr. Belise 

Livingston. Pet. Ex. 14 at 27. Dr. Livingston’s history of present illness includes the fact that 

B.R. received vaccinations four days prior to her admission, B.R.’s history of fever and left hip 

pain, and B.R.’s symptoms progressed to the point that “she began having marked difficulty 

ambulating.” Id. Dr. Livingston noted that B.R. had a history of borderline elevated blood 

pressure thought to be due to her obesity. Id. at 28. B.R. had no history of cough, wheezing, 

trouble breathing, or respiratory distress. Id. Dr. Livingston charted, “[t]he patient has had a 

sore throat off and on for the past week” and “[s]he did have some nausea with the sore throat.” 

Id. Dr. Livingston also included that “[t]he mother does report intermittent red rash that has 

come and gone for the past 3 days.” Id.

Dr. Livingston conducted a physical examination, noting that B.R.’s oropharynx was 

“mildly injected.” Pet. Ex. 14 at 28.7

 No significant adenopathy was present. Id. Respiratory 

sounds were clear bilaterally. Id. B.R. had tenderness of her left upper thigh and hip and she 

was unable to ambulate due to pain. Id. Dr. Livingston did not see any rashes or lesions at the 

time of her exam. Id. Consults were obtained from neurology and orthopedics. Id. at 29. The 

neurologist, Dr. Alan Little, found no evidence of acute neuropathy. Id. at 29, 31-32. The 

orthopedist, Dr. Thomas M. Darden, noted that B.R. received four vaccines, and his impression 

was “transient synovitis secondary to the viral load from the vaccine although cannot completely 

rule out the possibility of a bacterial sepsis of the joint.” Id. at 33. An MRI was ordered to 

evaluate for infection or septic joint. Id. at 34. 
8

2. Autopsies

Two autopsies were performed: the first was performed by Dr. Mark N. Burns, the 

Medical Director of the Laboratory and Pathologist at Phoebe Putney, and the second by Dr. 

Harry S. Latham, performed at the family’s request. See Pet. Ex. 14 at 83-84; Dr. Latham’s 

Autopsy Report (“Latham Autopsy”), filed June 2, 2017 (ECF No. 98).

a. Autopsy by Dr. Mark N. Burns

Dr. Burns performed the initial autopsy on April 7, 2009. Pet. Ex. 14 at 83. External 

examination revealed “prominate swelling of the left leg” with induration and discoloration of 

the left groin extending to the medial thigh and superiorly to the iliac crest. Id. at 83-84. Bullae 

with serosanguinous fluid were present. Id. at 84. External genitalia was unremarkable and 

there was “no palpable cervical, axillary, or inguinal lymphadenopathy.” Id. at 83.

Internal examination showed edema and hemorrhage, as well as “highly variable numbers 

of coccal bacteria” in the soft tissues of the left leg and thigh. Pet. Ex. 14 at 83, 87. The pleural 

(lung) surfaces were normal except some apical fibrous adhesions. Id. at 84. The cause of death

The preliminary interpretation of the MRI was edematous changes “noted within the 

muscular surrounding of the left hip compatible with myositis/rhabdomyolysis.” Pet. Ex. 14 at 

29. An abscess was not seen. Id. Dr. Livingston concluded that B.R.’s labs were “consistent

with an acute inflammatory process” suggesting possible infectious myositis. Id. at 29-30. She

ordered a rapid strep test, throat culture, and influenza (“flu”) testing to rule out “likely causes of

infectious arthritis or myositis.” Id. at 30. The tests were all negative. Id. at 66, 93. Dr.

Livingston noted that the blood culture was still pending. Id. at 30. Dr. Livingston stated that it

was not clear whether B.R.’s illness was related to her vaccinations. Id. at 58.

At 11:10 PM, the nursing staff received a call from Palmyra reporting that the blood 

cultures drawn earlier were positive, showing gram positive cocci in chains. Pet. Ex. 14 at 57, 

71. Dr. Livingston, was notified, and an antibiotic, ceftriaxone, was ordered. Id. at 57, 71.

Throughout the early hours of April 4, 2009, B.R. received medication for hip pain. See

Pet. Ex. 14 at 71. At 1:25 AM, she was given morphine, at 5:10 AM, she was given Toradol, 

and at 6:45 AM, she was again given morphine. Id. At 6:45 AM, her left hip was described as 

swollen, with bruising, and the skin was taunt. Id. At 9:30 AM, B.R. was found unresponsive 

but breathing. Id. at 61-62. Dr. Livingston arrived and a code was called. Id. at 62. B.R. was 

taken to the ED for emergent care because the ICU was full. Id. at 62, 81. B.R. progressively 

worsened and despite lengthy resuscitative efforts, she died at 12:27 PM on April 4, 2009. Id. at 

70, 81, 112-13. 

A VAERS report was filed on or about April 15, 2009. Pet. Ex. 42. The report contains 

a summary of information that appears to have been taken from B.R.’s medical records. See id.

On April 21, 2009, the death certificate was signed by Dr. Livingston, identifying 

necrotizing fasciitis (Group A Streptococcus) as the cause of death. Pet. Ex. 12. 
9

was “necrotizing fasciitis (gram positive cocci) with septic shock.” Id. at 83 (emphasis omitted). 

Tissue samples were taken from skin, lymph nodes, left perineal, groin, inguinal and hip, and 

spleen and liver. Id. at 87.

b. Autopsy by Dr. Harry S. Latham

Dr. Latham also concluded that necrotizing fasciitis due to gram positive cocci of the left 

upper leg, hip, and inguinal/groin area with septic shock was the cause of death. Latham 

Autopsy at 6. He described the external, internal, and microscopic findings relative to the left 

leg and thigh similarly to those noted by Dr. Burns. See id. at 3, 6. Unlike Dr. Burns, Dr. 

Latham performed a full autopsy to include all of the abdominal organs and brain. See id. at 4-5. 

Relevant to the issues here, he described the lungs as “markedly edematous and congested” but 

did not describe any evidence of pneumonia. Id. at 4. Under pathological diagnosis, Dr. Latham 

noted, 

Status post history of inoculations one day before onset of clinical symptoms. No 

distinct point of origin for the introduction of the Group A Beta Hemolytic 

Streptococcus (Streptococcus Pyogenes) is found. However, wounds as minor as 

pin pricks, needle punctures, bruises, blisters or abrasions are as serious as 

traumatic injury or surgical incision and can provide an opportunity for bacteria to 

enter the body. 

Id. at 6 (emphasis omitted). 

C. Deposition Testimony

As described above in the procedural history, petitioner filed a civil action against a 

number of defendants alleging medical malpractice arising out of the medical and nursing care 

provided to B.R. During the pendency of that action, a number of depositions were taken, which 

were later filed in this matter. A brief summary of each deposition follows.

1. Stephanie Roscoe

Ms. Roscoe’s deposition was taken on October 26, 2011. Resp. Ex. L at 1. She is the 

petitioner and mother of B.R. At the time of these events, she worked at Ryan’s Steakhouse. Id.

at 13.

On Tuesday, March 31, 2009, Ms. Roscoe had to work, so Mr. Parks took B.R. to the 

doctor for her routine appointment and vaccinations. Resp. Ex. L at 14, 87. Prior to that 

doctor’s visit, B.R. had no complaints of pain, and did not have a stuffy nose, cough, sore throat, 

or fever. Id. at 31-32. 

At approximately 3:00 AM the morning after her vaccinations, April 1, 2009, B.R. woke 

her mother and complained of leg pain. Resp. Ex. L at 36-37. B.R. felt warm. Id. at 38. She 

did not have a runny nose, cough, or sore throat. Id. at 35, 39. Ms. Roscoe had to work that day. 

Id. at 39. When she got home from work, B.R. continued to complain of leg pain and her skin 
10

2. Frederick Parks

Mr. Parks is the father of B.R. He gave his deposition on October 26, 2011. Resp. Ex. K 

at 1. In April 2009, Mr. Parks worked at W.W. Construction Company, pouring asphalt and 

concrete for parking lots. Id. at 7. 

Prior to B.R.’s vaccinations on March 31, 2009, she did not complain of hip pain, sore 

throat, headache, pain, cough, or runny nose. Resp. Ex. K at 14. 

After receiving the vaccinations, B.R. complained that her arms were a bit sore. Resp. 

Ex. K at 13, 18. The next day, April 1, 2009, after Ms. Roscoe came home from work, B.R. 

complained that her leg hurt. Id. at 22. After B.R. was seen at the hospital that day, she had a 

limp. Id. at 27. On April 2, 2009, B.R. laid in her bed most of the day. Id. at 30. She 

complained of leg pain. Id. The next day, April 3, 2009, Mr. Parks helped get B.R. in the car so 

that his wife could take her to the hospital. Id. at 37. Mr. Parks came to see his daughter at the 

hospital on April 3, and again on the morning of April 4. Id. at 40-42, 62.

3. Dr. Mark N. Burns

Dr. Burns attended the first two years of medical school at the University of South 

Dakota, then transferred and completed his medical training at Emory University. Resp. Ex. Y at 

5. He completed his residency in pathology at Emory, and then began practicing pathology at

Phoebe Putney in Albany, Georgia, where he worked until he retired. Id. at 5-6. Dr. Burns is

board certified in pathology. Id. at 6. In his capacity at the pathologist at Phoebe Putney, he

was hot. Id. at 40-41. Ms. Roscoe took B.R. to the Phoebe Putney ED, where B.R. was seen by 

Dr. Woodard. Id. at 42-43. B.R. did not have a cough, and did not complain of sore throat, ear 

pain, or chills. Id. at 44. She did have nausea and was limping. Id. at 44-46. Dr. Woodward 

diagnosed B.R. with a reaction to her vaccinations, and recommended Tylenol or Motrin for the 

fever. Id. at 47. 

The next day, April 2, 2009, Ms. Roscoe worked. Resp. Ex. L at 52. When she got home 

from work, B.R.’s limp was worse and it was more difficult for her to walk. Id. at 53-54. B.R. 

did not have any complaints of runny nose or cough. Id. at 54-55. About 6:00 AM the next 

morning, April 3, 2009, B.R. was really hot, in extreme pain, and unable to walk. Id. at 55-56. 

Ms. Roscoe took her to Palmyra. Id. at 57. After being seen at Palmyra, B.R. was transferred to 

Phoebe Putney by ambulance. Id. At Phoebe Putney, B.R. was seen by Dr. Livingston and an 

orthopedist Dr. Darden, and an MRI was performed. Id. at 59-62. 

After B.R. passed away, Ms. Roscoe and Mr. Parks wanted to know what caused B.R.’s 

death and decided to pay for a full autopsy to be performed. Resp. Ex. L at 67. 

In addition to filing her deposition from the civil case, Ms. Roscoe filed an affidavit in 

which she averred that B.R. did not have a “cough or cold prior to receiving the vaccine shots.” 

Pet. Ex. 37 at ¶ 13. 
11

worked in concert with the medical examiner or coroner to perform autopsies to determine the 

cause of death. Id. at 8-9. 

Dr. Burns testified that B.R. was the youngest patient with necrotizing fasciitis that he 

had ever seen. Resp. Ex. Y at 16. After completing his evaluation and autopsy, Dr. Burns was 

unable to determine the etiology of B.R.’s necrotizing fasciitis. Id. at 16-17. 

Dr. Burns defined necrotizing fasciitis as,

an uncommon infectious process that is rapid and life-threatening and requires 

rapid surgical and antimicrobial intervention. The most common sites of infection 

are the lower extremities, including the groin and perineal regions. It’s a bacterial 

infection which is rapidly progressing. There’s generally a site of entrance, 

usually a wound of some sort or a natural occurring defect in one of the natural 

body barriers, such as the skin or the bowel or the urinary or genital tract. The 

most common organism identified as Strep pyogenes.

Resp. Ex. Y at 22. In a majority of cases, “there’s a clearly apparent site of entry, a wound, or an 

infectious process and localized infection that is readily apparent as the origin of the process.” 

Id. at 23.

Dr. Burns was not able to identify a site of entry for the bacteria that caused B.R.’s 

illness. Resp. Ex. Y at 22-23. When asked whether B.R.’s vaccinations had anything to do with 

her illness, Dr. Burns answered no, that there was “no known scientific connection between such 

unrelated processes.” Id. at 23. 

Dr. Burns did not do a full autopsy; he did not examine the brain, lungs, or heart. Resp. 

Ex. Y at 20. He did examine the perineal area and the external genitalia, which were 

unremarkable. Id. at 72, 74. Further, there was no inguinal lymphadenopathy. Id. at 72.

4. Dr. Harry S. Latham

Dr. Latham attended medical school at the University of North Carolina, and then began 

his residency in clinical and anatomical pathology in Palo Alto, California, and finished it at the 

Medical College of Virginia, in Richmond, Virginia. Resp. Ex. J. at 6. He started his practice in 

Burlington, North Carolina, and then moved to Union and Gaffney, South Carolina. Id. at 7-8. 

He later moved to Cordele, Georgia, where he worked at Crisp Regional Medical Center. Id. at 

8. He has performed approximately 1,600 autopsies over his 40-year career. Id. at 11-12.

Dr. Latham testified that “there was a very good likelihood that the vaccinations may 

have been the cause” of B.R.’s infection, “[a]nd that was strictly because of time and effect of 

the event.” Resp. Ex. J. at 28. He explained that the cause of necrotizing fasciitis is not always 

known, “[i]t can be just a small prick and the bacteria get into the body.” Id. at 28-29. Dr. 

Latham expounded on his opinions as follows:
12

Id. at 29.

There was no area seen at autopsy that Dr. Latham was able to identify as a site for the 

introduction of bacteria and no evidence of injury. Resp. Ex. J. at 30-31. Further, Dr. Latham 

testified that B.R. did not have strep throat. Id. at 35, 37. 

When asked how long B.R. had the infection, Dr. Latham responded that the type of 

bacteria B.R. had causes symptoms fairly quickly and that the pain she had the day after 

vaccination was caused by the infection. Resp. Ex. J. at 38-39.

5. Dr. Belise Livingston-Burns

Dr. Livingston-Burns8gave a deposition on June 25, 2013. Resp. Ex. W at 1. She 

attended medical school at the University of Chicago, Pritzker School of Medicine, and did her 

residency in pediatrics at Emory University School of Medicine. Id. at 7. Dr. Livingston-Burns 

practiced two years at a National Health Service clinic in Lake City, Florida, then joined the 

Albany Area Primary Health Care practice. Id. at 8.

Dr. Livingston-Burns recalls that B.R.’s presentation on April 3, 2009, was concerning 

for Guillain-Barré syndrome (“GBS”) following vaccination or viral myositis, due to her 

difficulty walking, leg weakness, and recent vaccines. Resp. Ex. W at 13-14, 25. Her ultimate 

diagnosis was necrotizing fasciitis and sepsis. Id. at 15. Necrotizing fasciitis was low on the list 

of differential diagnoses because B.R. had no open wounds and no history of trauma. Id. at 15-

16. Dr. Livingston-Burns documented that there were no wounds or lesions noted on B.R.’s

skin. Id. at 59.

Due to concern regarding GBS, Dr. Livingston-Burns consulted Dr. Little, a neurologist. 

Resp. Ex. W at 31. After consultation, Dr. Little’s impression was septic versus inflammatory 

arthritis of the left hip, and he recommended an orthopedic consult who ordered an MRI. Id. at 

33-35. The MRI showed edematous changes in the muscle adjacent to the left hip consistent

with myositis/rhabdomyolysis with no evidence of abscess. Id. at 38. At that point, Dr.

Livingston-Burns ordered an infectious disease consult. Id. at 39. She considered a viral illness,

and ordered flu and strep testing, along with other lab studies. Id. at 43-44. The evening of

8 Dr. Livingston changed her surname to Livingston-Burns sometime between treating B.R. and 

giving her deposition. See Resp. Ex. W at 5, 7.

The reason I thought it might have been the inoculations is simply because she got 

the inoculations the morning or maybe afternoon of the 31st of March and, within 

12 hours or so, she was complaining of pain in her hip. And while it’s possible 

she got an injury somewhere else that introduced the organisms into her body, 

likelihood, to me, is that it could have been from the inoculations because either 

sterility wasn’t obtained before they did the injection[s] and it was introduced—

because we have bacteria all over our body, including beta Strep. And it just 

resides there. Normally it doesn’t cause problems. But if it gets introduced into a 

certain area where it can grow well, that’s when the problems occur.
13

April 3, Dr. Livingston-Burns was notified that B.R.’s blood culture was positive for grampositive cocci in chains, and she suspected some type of Streptococcus, so she ordered

antibiotics. Id. at 49-52. 

Dr. Livingston-Burns did not offer any opinion as to the source of B.R.’s infection and 

necrotizing fasciitis. Resp. Ex. W at 124. She believed that a report was filed regarding the 

B.R.’s vaccinations and the problems she had afterward, but she was not involved in that

process. Id. at 125-26.

6. Dr. David Kocherla

Dr. Kocherla’s deposition was taken on September 5, 2012. Resp. Ex. X at 1. Dr. 

Kocherla attended medical school in India, and then took specialized training in general surgery, 

also in India. Id. at 5-6. He practiced general surgery in India and Iran, and then in 1994 came 

to the United States, where he completed a three year residency in internal medicine at Long 

Island Jewish Hospital in New York. Id. at 6-7. After completion of his residency, he moved to 

Albany, Georgia, where he joined a practice doing internal medicine, family practice, and 

emergency room care. Id. at 8. Subsequently, he joined Palmyra as a full-time emergency 

medicine physician. Id. at 9.

Dr. Kocherla provided care to B.R. when she presented to the Palmyra ER on April 3, 

2009. Resp. Ex. X at 23-24. Her chief complaints were fever, rash, inability to walk, 

polymyalgia, and polyarthralgia. Id. at 28-29. She had pain in the left hip, left knee, lower limb 

myalgia, and lower leg weakness due to pain. Id. at 30. B.R. also had a rash on her neck. Id. at 

40, 42. Dr. Kocherla’s suspected that B.R. had sepsis and a septic joint due to the tenderness in 

her left hip and knee and fever. Id. at 37-43. He was aware that she had received four 

vaccinations four days before, and thought the condition was related to vaccination, and 

questioned whether she had a rheumatological process. Id. at 42-43. His diagnosis was “postvaccination reaction,” and he ordered a sepsis work up. Id. at 33-34, 37-43. 

After Dr. Kocherla reviewed lab results, specifically the elevated sedimentation rate of 

57, he thought that B.R. had sepsis or “post-vaccination myopathy.” Resp. Ex. X at 53, 56-58. 

Dr. Kocherla cited UpToDate “[u]nder post-vaccination reactions” as a resource providing 

information about a vaccination reaction that caused focal pain in the hip and thigh. Id. at 54. 

After reviewing the lab results, Dr. Kocherla’s diagnosis was “unexplained pain in the upper 

thigh” which could represent myopathy, a rheumatology problem, infection, abscess, sepsis, 

infected joint, infected tissues, and possibly bone infection. Id. at 58. His working diagnoses 

were “post-vaccination reaction, polyarthralgia, [and] serum sickness.”9 Id. Because B.R. had a 

rash, Dr. Kocherla also considered that B.R. might have “Still’s Disease or juvenile rheumatoid 

arthritis,” which presents with “rash, fever, and pain in the joints.” Id. at 71. He ordered that 

B.R. be transferred to Dr. Livingston at Phoebe Putney for pediatric care. Id. at 33-34, 49-50. 

9 Serum sickness is “a hypersensitivity reaction to the administration of foreign serum or serum 

proteins characterized by fever, urticaria, arthralgia, edema, and lymphadenopathy.” Serum 

Sickness, Dorland’s Med. Dictionary Online, https://www.dorlandsonline.com/dorland/

definition?id=106046 (last visited May 27, 2020).
14

7. Dr. Robert W. Mills

Dr. Mills’ deposition was taken July 9, 2013. Pet. Ex. 18 at 1. He attended medical 

school and completed a residency in pediatrics at the Medical College of Ohio. Id. at 13-14. He 

is in private practice and the Medical Director at Mercy Children’s Hospital in Toledo, Ohio. Id.

at 18.

Unlike the other physicians who gave a deposition, Dr. Mills did not provide any medical 

care to B.R.; instead, he was plaintiff’s expert in the medical malpractice case. Dr. Mills 

submitted an expert affidavit, in which he testified that the nurses at Phoebe Putney violated the 

standard of care by failing to notify a physician on April 4, 2009 of B.R.’s vital signs at 12:00 

midnight (BP 76/52, heart rate 140, and respiratory rate 36) and at 4:00 AM (BP 90/48, heart rate 

140, and respiratory rate 32). Pet. Ex. 15 at ¶¶ 7(o)-7(r), 10. Dr. Mills’ affidavit was required 

under Georgia law to support a complaint for malpractice against the defendant, Phoebe Putney. 

Pet. Ex. 18 at 32. 

Dr. Mills’ deposition testimony generally focused on his opinions as to the nursing care. 

Pet. Ex. 18 at 58. During his deposition, Dr. Mills was asked whether B.R.’s immunizations 

played any role in the development of her illness, and he testified that it was “highly, highly 

unlikely.” Id. at 45-46. Dr. Mills stated that since B.R. had the vaccinations in her arm, they 

were unlikely to seed the infection in her leg. Id. at 46. He explained that in children, infection

can seed through mucus membranes, or the nose, throat, or skin. Id. He also testified that little 

breaks, even tiny breaks in the skin, can seed infection and cause bacteremia. Id. He noted that 

B.R. had a history of a sore throat, but acknowledged that her strep screen came back negative. 

Id. at 47. Dr. Mills also questioned whether minor muscle trauma from jogging (described in 

B.R.’s father’s deposition) may have incited the infection, but conceded that opinion was

speculative. Id.

D. Affidavits from Family Members and Pastor Mary Whitley

Several affidavits were executed by family members and Pastor Mary Whitley. See Pet. 

Exs. 33-40. Relevant to the causation issues addressed in this Ruling are statements about B.R.’s 

health prior to her vaccinations and/or death. Brittany Parks, B.R.’s sister, lived in the same 

house and shared a bedroom with her sister. Pet. Ex. 38 at ¶ 5. She averred that she “did not 

observe or witness her sister having any complications with coughs or cold immediately prior to 

her death.” Id. at ¶ 8. Terry Roscoe, B.R.’s brother, similarly testified that “[his] sister never 

exhibited complications with colds or rash or the like prior to being administered the vaccine 

shots.” Pet. Ex. 39 at ¶ 7. Pastor Whitley testified that prior to the vaccinations, B.R. “never 

complained about flu or cold or anything of that nature.” Pet. Ex. 40 at ¶ 6. 

E. Expert Reports

The experts agreed as to the cause of death, necrotizing fasciitis with septic shock due to 

a bacterial infection caused by Streptococcus pyogenes; however, they disagreed as to how B.R. 

“came to be infected” with the bacteria. Resp. Ex. Z at 1; see also Pet. Ex. 43 at 6-8. Dr. Miller 

opined that the source of bacteria was B.R.’s vaccinations, whereas Dr. Vargas opined that it 
15

came from the throat, the genital tract, or an unknown origin. Pet. Ex. 43 at 6-8; Resp. Ex. Z at 

1-5.

Both experts reviewed the medical records, the autopsy reports, and the autopsy tissue 

slides. Pet. Ex. 43 at 1; Resp. Ex. A at 1; Resp. Ex. M at 1-2. The medical records do not 

document redness, warmth, or swelling at B.R.’s vaccination sites. Resp. Ex. A at 7. 

1. Petitioner – Dr. Douglas Miller, M.D.

a. Background and Qualifications

Dr. Miller is a physician, certified in both neuropathology and anatomic pathology by the 

American Board of Pathology. Pet. Ex. 43 at 1. He earned his B.A. from Williams College in 

Massachusetts in 1974. Pet. Ex. 44 at 1. He then attended University of Miami where he earned 

both his M.D. and Ph.D. Id. Thereafter, Dr. Miller completed an anatomic pathology residency 

from 1980 to 1982 and a neuropathology residency from 1982 to 1984 at Massachusetts General 

Hospital. Id. Since 1984, he has spent his career in academic pathology. Pet. Ex. 43 at 1. Dr.

Miller currently works as a Clinical Professor in the Department of Pathology & Anatomical 

Sciences, Interim Chair of the Department of Pathology & Anatomical Sciences, and the 

Pathology Residency Director at the University of Missouri School of Medicine. Id. 

Throughout his career, he has served as a consultant to medical examiners requiring 

neuropathology subspecialty expertise. Id. at 1-2; Pet. Ex. 44 at 3. Dr. Miller serves on various 

committees and editorial review boards and has authored or co-authored almost 300 publications. 

Id. at 4-26. 

b. Opinion

i. Althen Prong One

There are two tenets to Dr. Miller’s theory of causation. The first tenet is that 

Streptococcus pyogenes is a well-known cause of skin and other infections. Pet. Ex. 43 at 7. 

This aspect of Dr. Miller’s theory is not in dispute.

The second tenet of Dr. Miller’s mechanism of causation is that Streptococcus pyogenes

bacteria can be distributed through the blood stream to various body sites. Tr. 61, 68-69; Pet. Ex. 

43 at 7-8. This mode of infection is referred to as hematogenous spread. Tr. 105. Tissue with 

less perfusion that receives less blood flow, like the fatty area of the thigh, can create a location 

for infection to set up, particularly in obese persons. Tr. 61. Bacteria grows better in fatty areas 

than in other body tissue. Id. Dr. Miller opined that a bacterial infection can occur in a site 

remote from the place where the infection entered the body. Tr. 59-61. Specifically, he testified 

that in cases of hematogenous spread of bacteria, an infection can occur at a remote site even if 

there are no symptoms of infection at the site where the bacteria entered the body. Tr. 67-70, 91. 
16

Dr. Miller also referenced an article filed by respondent, authored by Ian F. Cook.

11 Tr.

63-65 (citing Resp. Ex. N). Cook reviewed adverse infectious events that occurred after

vaccination, to emphasize the importance of skin disinfection before administering vaccines. Tr.

65. Dr. Miller explained that bacteria can be introduced into the body through the skin via

injection, and that is why it is important to sterilize the skin prior to vaccine injection. Tr. 68-69,

85. Even proper disinfection technique does not completely sterilize the skin, and there is some

chance for bacteria to be carried through the skin by a needle even if the person who administers

the vaccine follows proper procedure. Tr. 86.

Cook reviewed data from a number of sources, including the VAERS database, Vaccine 

Safety Datalink (“VSD”) program, Korean, Italian, and Canadian surveillance programs, Kaiser 

clinics, Medicare, and published reports in the medical literature. Resp. Ex. N at 2-3. He 

reported 1534 cases of sepsis12 following vaccinations, noting that the majority (65.9%) were 

associated with cellulitis.13 Id. at 8.

Twelve cases of necrotizing fasciitis were summarized in a Table in the Cook article:

seven from the literature and five from the VAERS database. Resp. Ex. N at 6-7 tbl.5. One of 

the case reports in the table was from a paper authored by Thomas,14 about an 80-year-old 

patient who received the flu vaccine in her left upper arm. Id. at 6 tbl.5 (citing Resp. Ex. BB).

Two days later, the patient presented with a blue discoloration of her left forearm, “blister-like 

10 Streptococcal and Enterococcal Infections, Merck Manual, https://www.merckmanuals.com/

professional/infectious-diseases/gram-positive-cocci (last visited Sept. 11, 2013).

11 Ian F. Cook, Sepsis, Parenteral Vaccination and Skin Disinfection, 12 Hum. Vaccines & 

Immunotherapeutics 2546 (2016). 

12 Cook defined sepsis as a systemic inflammatory response syndrome which occurs when 

infection is associated with organ dysfunction, hypoperfusion, and/or hypotension. Resp. Ex. N 

at 8. 

13 Cellulitis is defined as “an acute, infectious and expanding inflammatory condition of the 

skin.” Resp. Ex. N at 2. 

14 M.G. Thomas, Clostridium Septicum Gas Gangrene Following Intramuscular Infection from 

an Influenza Vaccine Booster, 44 British J. Clinical Prac. 709 (1990). 

In support of his theory of causation, Dr. Miller cited the Merck Manual, a guidebook for 

physicians. Tr. 58 (citing Pet. Ex. 26).10 With regard to necrotizing fasciitis due to 

Streptococcus pyogenes, the Merck Manual states that “[i]noculation originates through the skin 

or bowel, and the defect may be surgical, trivial, distant from the disease site, or occult, as with 

colonic diverticula or an appendiceal abscess.” Pet. Ex. 26 at 4. Thus, the defect where the 

bacteria enters the body can be trivial, and Dr. Miller emphasized that the site of bacteria entry 

may be distant from the disease it causes. Tr. 59-61. 
17

1) Male, age 72, had an influenza vaccine given in his left arm. Id. at 9 tbl.7. He

developed pain and swelling in his right wrist, arm, and left ankle. Id. Group A

strep was cultured from the right wrist. Id.

15 Clostridium septicum is defined as “a toxicogenic species commonly found in animal 

intestines and soil, causing diseases such as braxy and malignant edema; in humans it is 

sometimes associated with gas gangrene.” Clostridium Septicum, Dorland’s Med. Dictionary 

Online, https://www.dorlandsonline.com/dorland/definition?id=65642 (last visited May 27, 

2020).

16 Osteomyelitis is the “inflammation of bone caused by infection, usually by a pyogenic 

organism, although any infectious agent may be involved.” Osteomyelitis, Dorland’s Med.

Dictionary Online, https://www.dorlandsonline.com/dorland/definition?id=35862 (last visited 

May 27, 2020).

17 This is the British spelling of the word, hematogenous. For clarity, the English spelling will be 

used throughout this Ruling.

18 Dr. Miller defined hematogenous as “spread in the bloodstream.” Tr. 105.

19 Septic arthritis is an “infection of the joint.” Resp. Ex. N at 5. 

fluid collections” or bullae, and a “cold, pulseless left hand.” Tr. 64 (citing Resp. Ex. N at 6 

tbl.5). The fluid in the lesions cultured clostridium septicum.15 Id. (citing Resp. Ex. N at 6 

tbl.5). Dr. Miller testified that based on the description provided in Cook, the injection site was 

the upper left deltoid muscle, and the “subsequent soft tissue infection was in the forearm and 

hand, without a direct connection to the vaccination site.” Tr. 64-65. Dr. Miller noted that the 

infection was remote from the vaccine site. Tr. 65. 

Cook also described ten cases of osteomyelitis16 following vaccination. Resp. Ex. N at 5. 

Cook identified three mechanisms of infection spread: haematogenous17 and contiguous spread 

with or without vascular insufficiency. Id. One case was due to hematogenous spread18 after flu 

vaccination in the right arm of the patient. Id. at 5, 8 tbl.6. The patient’s clinical history was 

notable for cellulitis in the right arm and the patient developed L3-4 vertebral osteomyelitis. Id. 

at 8 tbl.6. Dr. Miller explained that the mechanism of hematogenous spread of bacteria in the 

blood stream described in the patient in Cook’s article was the same “mode of spread” in B.R.’s 

case. Tr. 105. 

Septic arthritis19

 was another type of adverse infection occurring after vaccination 

reported by Cook. Resp. Ex. N at 5, 9 tbl.7. Hematogenous spread was reported in four cases of 

septic arthritis: 
18

2) Female, age 1 year, 1 month, had Hepatitis A and Varicella vaccinations in the

left leg, and subsequently was unable to move her left elbow. Id. Aspirate of the

left elbow was positive for Alcaligenes faecalis.

20

 Id.

3) Male, age unknown, had Hepatitis B vaccination in the left leg and developed

pain and decreased movement in the left leg, and was diagnosed with septic

arthritis of the left hip and ankle. Id. Blood cultures showed methicillinsusceptible Staphylococcus aureus21 (“MSSA”), as did left ankle ulcer. Id.

4) Male, age 16, received the meningococcal and Tdap vaccines in his right arm, and

developed methicillin-resistant Staphylococcus aureus (“MRSA”) bacteremia

with left sacroiliac joint, and septic arthritis on bone scan and MRI. Id.

There was no mention of symptoms of infection at the site of vaccination in the four 

cases described above, where the route of spread was hematogenous. See Resp. Ex. N at 9 tbl.7. 

Dr. Miller testified that the case involving the 16-year-old male who had a distant site infection

illustrates his causal theory. Tr. 110-11. 

Dr. Miller also cited another article filed by respondent, authored by Stevens et al.,22 in 

support of his opinions. Tr. 65-67 (citing Resp. Ex. Z, Tab 4). The article describes patients 

who had severe Group A Streptococcal infections. Tr. 66. Dr. Miller notes that “some of the 

patients did not have any documented portal of entry,” explaining that these patients had 

negative throat cultures and demonstrated no sign of injury to the skin. Tr. 67. Of the patients 

with no evidence of skin infections, one had a “bacterial infection of the interior of the eye 

globe” or “endophthalmitis.” Id. Dr. Miller opined that the patient with the eye infection had an 

infection from a source that was “clearly a distant site” and “no detectable site of entry.” Id. 

Therefore, Dr. Miller concluded that the infection had “to be carried in the bloodstream.” Id.

ii. Althen Prong Two

The autopsy established that B.R. had Streptococcus pyogenes, a bacteria that Dr. Miller 

opines is known to be present on human skin, and a known cause of human infections. Pet. Ex. 

20 Alcaligenes faecalis is “a species isolated from hospital environments and from blood, sputum, 

and urine specimens.” Alcaligenes Faecalis, Dorland’s Med. Dictionary Online, 

https://www.dorlandsonline.com/dorland/definition?id=55314 (last visited May 27, 2020).

21 Staphylococcus aureus is “a species comprising the yellow-pigmented, coagulase-positive 

pathogenic forms of [Staphylococcus]” that “causes serious suppurative infections and systemic 

disease, including impetigo bullosa, staphylococcal pneumonia, and staphylococcal scalded skin 

syndrome, and has developed resistance to nearly all classes of antibiotics.” Staphylococcus 

Aureus, Dorland’s Med. Dictionary Online, https://www.dorlandsonline.com/dorland/

definition?id=108211 (last visited May 27, 2020).

22 Dennis L. Stevens et al., Severe Group A Streptococcal Infections Associated with a Toxic 

Shock-like Syndrome and Scarlet Fever Toxin A, 321 New Eng. J. Med. 1 (1989).
19

23 Dr. Miller’s complete review of B.R.’s medical records will not be recounted in this section. 

For a more detailed summary of relevant facts, see supra Section III.B.1.

43 at 7. Dr. Miller opines that the “autopsy findings are consistent with septic shock from an 

infection centered in the left hip region.” Id. at 4. According to Dr. Miller, bacteria got into the 

bloodstream at the site of one of B.R.’s vaccinations, and once in the bloodstream, traveled to the 

thigh, an area of high fat content. Tr. 69. Dr. Miller opines that there was no source of infection 

other than vaccination as evidenced by the autopsy. Pet. Ex. 43 at 6. 

Dr. Miller disagrees with respondent’s position that B.R. likely had strep throat, or other 

infection that caused her necrotizing fasciitis and septic shock. Pet. Ex. 43 at 6. He opines that 

the clinical history does not provide evidence of any other source or site of infection. Id. At the 

hearing, Dr. Miller painstakingly reviewed the medical records in chronologic order to support 

his position that there was no evidence of strep throat that could have been the source of B.R.’s 

necrotizing fasciitis.23 See Tr. 13-57. 

Dr. Miller began by stating that on March 31, 2009, at B.R.’s well child visit, she had no 

complaints, her vital signs, lab tests, and urinalysis were normal, and there were no identifiable 

illnesses. Pet. Ex. 14 at 3-4; Tr. 14. The only issue noted was B.R.’s weight. Tr. 14. Four 

vaccines were administered at this visit, two in each arm. Pet. Ex. 14 at 4; Tr. 15. 

On April 1, 2009, B.R. was seen in the Phoebe Putney ED at 5:45 PM, complaining of 

hip pain and fever that began that morning at 3:30 AM. Pet. Ex. 14 at 10-12; Tr. 16. B.R. had 

no infectious disease risk factors, no contacts with illness, had been acting normally, was voiding 

urine, had no ear pain, had no vomiting or diarrhea, felt hot, and was febrile for two-and-one-half 

hours. Tr. 17. B.R. denied injury to the hip, and had a fever of 102 to 103. Id.; Pet. Ex. 14 at 

11. There was no history of cough, sore throat, stuffy or runny nose, chills, or sweats, and her

appetite was okay. Pet. Ex. 14 at 11. A physical exam found B.R. had no ear, nose, or throat

abnormalities, her neck was supple, she had no significant adenopathy (no enlarged lymph nodes

in her neck, face, or head), and her oropharynx (throat) was clear with no inflammation or

evidence of otitis media (ear infection). Id. at 12; Tr. 18-19. She had good breath sounds, no

labored breathing, no coughing, and no wheezing. Pet. Ex. 14 at 12; Tr. 19. Lastly, her

abdomen was soft with no palpable or enlarged organs, she had good bowel sounds, she had

“moderate tenderness to palpation over the left anterior thigh,” and her skin was clear with no

rash. Tr. 20; see Pet. Ex. 14 at 12.

Based on the clinical history and physical examination on April 1, Dr. Miller concluded 

there was no evidence that B.R. had strep throat. Tr. 20. Specifically, he testified that she had 

no inflammation in her throat and no enlarged lymph nodes, which he finds typical for a patient 

with strep throat. Id. However, Dr. Miller opined that there was evidence that B.R.’s leg was 

infected on April 1 because she complained of pain and her leg was tender to palpation. Tr. 20-

21. 

Next, Dr. Miller recounted that B.R. was next seen by a physician on April 3, when she 

presented to the Palmyra ER with a high fever and “[e]xtreme upper thigh pain.” Pet. Ex. 14 at 

120, 133; Tr. 21. She was again noted to have no cough, no shortness of breath or difficulty 
20

24 A CDC monograph on Group A Strep and scarlet fever, filed as Respondent’s Exhibit Z, Tab 

6, describes symptoms of strep throat as very red, sore throat, fever, whitish coating on the 

tongue, and swollen glands in the neck, consistent with Dr. Miller’s testimony on this point. 

Group A Streptococcal (GAS) Disease, Ctrs. for Disease Control & Prevention, 

https://www.cdc.gov/groupastrep/diseases-public/scarlet-fever.html (last visited July 13, 2019).

breathing, no sore throat, no close contact with anyone who had respiratory symptoms, and no 

contact with any person having a flu-like illness. Pet. Ex. 14 at 133; Tr. 22. Physical exam 

revealed B.R. was in mild distress. Pet. Ex. 14 at 120; Tr. 23. She had normal breath sounds, an 

exam of her head, ears, eyes, nose, and throat was normal, she had no history of trauma, and her 

skin was warm and intact with no breaks or lesions. Pet. Ex. 14 at 120; Tr. 23-25. Based on the 

medical records from April 3, Dr. Miller concluded that there was no evidence that B.R. had 

strep throat. Tr. 26. 

Dr. Miller testified that B.R. was transferred from Palmyra to Phoebe Putney later that 

day and the admitting pediatrician, Dr. Livingston, documented a history and physical exam. Tr. 

27-28, 34; see Pet. Ex. 14 at 27-30. On exam, B.R. had no nasal discharge, no cough, no

wheezing, and no trouble breathing. Tr. 36. Dr. Livingston stated, “[t]he patient has had a sore

throat off and on for the past week” and had “some nausea with the sore throat.” Pet. Ex. 14 at

28. B.R. had no pain on urination. Id. She had leg weakness, worse pain in the left hip and

thigh, and decreased ambulation. Id. Dr. Livingston also noted that B.R.’s mother reported that

B.R. had an “intermittent red rash that had come and gone for the past 3 days.” Id. Physical

examination revealed B.R.’s oropharynx was “mildly injected,” there was “[n]o significant

adenopathy,” and her lungs were clear. Id. Dr. Miller testified that the phrase “mildly injected”

suggests mild irritation or inflammation. Tr. 38. Given the history of vomiting at this point, Dr.

Miller stated that the note about B.R. having a sore throat was possibly related to irritated mucus

membranes from vomiting, but admitted that without more information, the finding was difficult

to interpret. Id.

The next physical exam occurred the morning of April 4, at 9:35 A.M. Tr. 39; see Pet. 

Ex. 14 at 61. At that time, an exam revealed that B.R. had moist mucus membranes without 

inflammation, no cough, and clear lungs. Pet. Ex. 14 at 61. 

In summary, Dr. Miller testified that B.R. had five consecutive examinations of her 

throat: March 31, April 1, April 3, evening of April 3, and the morning of April 4. The note on 

April 3 from Phoebe Putney is the only time that any abnormality is seen and documented, and 

thus, it is inconsistent with all of the other contemporaneous entries. Tr. 37. Dr. Miller also 

explained that a child with acute strep throat would have an inflamed throat, often with white 

follicles and exudate. Tr. 40. Thus, the description by Dr. Livingston on April 3 of “mildly 

injected” is not consistent with acute strep throat.24 Id. Further, the rapid strep test and throat 

culture done on the evening of April 3 were negative. Tr. 32. The throat culture showed no 

evidence of a strep organism. Id. Dr. Miller testified that the accuracy rate of a rapid strep test 

combined with a throat culture is 90-95% sensitive. Tr. 32, 71. Thus, he concludes that there is 

no evidence “at all” that B.R. had strep throat. Tr. 33. 
21

25 For the cases cited in Cook documenting a hematogenous spread of infection, see supra

Section III.E.1.b.i.

Dr. Miller also disagreed with respondent’s suggestion that B.R. had pneumonia or 

bacterial bronchitis. Pet. Ex. 43 at 6. The lung tissue slides showed “marked congestion and . . . 

intra-alveolar hemorrhage,” as well as “considerable desquamation of alveolar and bronchiolar 

lining cells and alveolar macrophages, as a terminal and autolytic phenomenon,” but there was 

no pneumonia or indication of a prior infection of the lungs. Id. at 4-5. Dr. Miller disagrees with 

respondent’s expert, Dr. Vargas, that lung tissue slide Q shows “early bronchopneumonia”

because Dr. Vargas did not identify any evidence of “early bronchopneumonia” in the other three 

lung slides. Id. at 5. The areas of lung tissue identified as abnormal by Dr. Vargas are, 

according to Dr. Miller, artifactual or terminal findings. Id. at 6. Dr. Miller also referred to these 

findings as “agonal,” which are changes that occur during death, and “autolysis,” or changes that 

occur when there is a delay in conducting an autopsy. Tr. 195-96. To the extent that there were 

any changes consistent with early pneumonia, Dr. Miller opined they would be a consequence of 

B.R.’s septicemia, and not a preceding infection. Tr. 196. Dr. Miller also notes that B.R.’s

records include many statements that her lungs were clear, except a note close in time to her

death, where she was noted to be in mild respiratory distress. Id.

Dr. Miller stated that the pathologists who performed the autopsies did not opine that 

B.R.’s infection started in her throat. Tr. 51-52. B.R.’s urine culture was also negative and not

compatible with streptococcus. Tr. 56. Dr. Miller opined that there was no evidence of a urinary

tract infection as the course of the infection in B.R.’s medical records. Tr. 70. There was no

history of trauma, no other breaks in the skin. Tr. 72. There was no reason for the treating

physicians to culture the genital tract as there were no symptoms to suggest that was the source

of infection. Tr. 91. Dr. Miller concluded that other than her vaccinations, there is no other

explanation as to the cause of B.R.’s infection. Tr. 71.

Dr. Miller agreed that there was no evidence of a local infection at the site of B.R.’s 

vaccinations. Tr. 91. He pointed out that the Stevens article documented a remote infectious 

complication (endophthalmitis) from an unknown site of entry. Tr. 89 (citing Resp. Ex. Z, Tab 

4). Dr. Miller conceded that in the cases of remote infections cited in Cook, most had an 

infection at the injection site; however, there were also cases cited in Cook that documented a 

hematogenous spread of infection, in the same manner that Dr. Miller’s asserts occurred in 

B.R.’s case, where there was no infection described at the site of vaccination. Tr. 89-90, 107-11

(citing Resp. Ex. N at 9 tbl.7).25

Consistent with the autopsies, Dr. Miller testified that B.R.’s cause of death was 

necrotizing fasciitis with septic shock, caused by Streptococcus pyogenes. Tr. 48-49. Dr. Miller 

explained that Streptococcus pyogenes is ubiquitous in the environment and on our skin. Tr. 50. 

While soft tissue infections like B.R.’s are very rare, they can be fatal. Tr. 51. 

Dr. Miller testified that here, there was bacteria on the needle as it penetrated the skin, 

and the bacteria was deposited into the subcutaneous tissues, or “penetrate[d] a blood vessel,” 

thus getting into the bloodstream. Tr. 111. At the cellular level, Dr. Miller explained that B.R. 
22

iii. Althen Prong Three

Dr. Miller testified that the onset of B.R.’s illness, the time frame between her 

vaccinations and thigh pain, was approximately 14 hours. Tr. 69-70. According to Dr. Miller, 

this time frame was appropriate given his proposed mechanism of causation. Tr. 70. In support 

of his opinion as to onset, Dr. Miller cites a case described in the Stevens article, where a patient 

had a fulminant presentation within eight hours of presentation. Id. (citing Resp. Ex. Z, Tab 4 at 

2). Dr. Miller opined that 14 hours was a sufficient time for bacteria to enter the bloodstream 

and seed an infection in the soft tissue and muscle of B.R.’s left hip. Tr. 96-97. 

2. Petitioner – Dr. Harry Latham

Petitioner filed four experts reports authored by Dr. Latham. See Pet. Exs. 22-25. Dr. 

Latham was not called as a witness at the hearing. 

In his first report, an affidavit, Dr. Latham provided a summary of B.R.’s medical 

records. See Pet. Ex. 22 at ¶ 5. He then opined in a conclusory fashion that “there is no 

evidence to suggest a cause for [B.R.’s] symptoms and disorders other than the vaccinations; 

and, [B.R.’s] injuries and death five days later were related to the administration of her . . .

vaccinations.” Pet. Ex. 22 at ¶ 6.

Dr. Latham provided four reasons for his causation opinion in his second report. The 

first reason was the onset of B.R.’s illness: the time frame between vaccination on March 31, 

2009, at about 1:00 PM, and the onset of pain on April 1, at approximately 3:00 AM, indicates a 

“strong temporal association” which “speaks [to] cause and effect.” Pet. Ex. 23 at 1. Second, 

B.R. received four vaccines, two in each arm. Id. Third, while Dr. Latham acknowledged that 

the “area affected by necrotizing fasciitis was not at the site of vaccination,” he noted that 

“necrotizing fasciitis has been documented to occur in areas away from the apparent point of 

26 For a more detailed analysis of the facts in the autopsy reports that contribute to Dr. Miller’s 

opinion, see Pet. Ex. 43 at 3-6. 

had “transient bacteremia” and the bacteria that entered the bloodstream from the vaccination 

seeded the soft tissue of the hip and thigh. Tr. 103, 111. Then, she developed an infection of the 

bloodstream and septic shock as a final complication. Tr. 103-04. Dr. Miller said that Cook 

describes this as “metastatic,” meaning that it spreads from somewhere else. Tr. 104-05. 

In summary, Dr. Miller opined that B.R. was previously healthy, but mildly obese, and 

was “given a clean bill of health” on the day she received four different injectable vaccinations. 

Pet. Ex. 43 at 8. Within 15 hours, she had left hip pain and fever. Id. She developed septicemia 

and septic shock, which caused her death. Id. She was diagnosed with a streptococcal infection. 

Tr. 97. She had no infection in her throat. Id. There is no evidence that she had evidence of 

genital infection. Id. She had four needle punctures that violated the skin. Id. Autopsy did not 

show any source for the bacteria.26 Pet. Ex. 43 at 8. For all of these reasons, Dr. Miller 

concluded that bacteria was introduced into the bloodstream by a vaccination, “a rare but 

reported complication” of vaccination administered by needle injection. Id.; see also Tr. 96-97. 
23

3. Respondent – Dr. Sara Vargas, M.D.

a. Background and Qualifications

Dr. Vargas is a doctor licensed to practice in Massachusetts and board-certified in 

anatomic pathology, clinical pathology, and pediatric pathology. Resp. Ex. A at 1. Dr. Vargas 

earned her A.B. from Harvard University in 1988 and her M.D. from University of Vermont 

College of Medicine in 1994. Resp. Ex. AA at 1. She then completed a residency in anatomic 

and clinical pathology at Brigham and Women’s Hospital and a fellowship in pediatric pathology 

at Children’s Hospital. Id. Since completing her residency and fellowship, Dr. Vargas has 

taught at Harvard Medical School as an Instructor, Assistant Professor, and now Associate 

Professor and has also worked as a staff pathologist at Children’s Hospital and Brigham and 

Women’s Hospital. Id. at 1-2; Resp. Ex. A at 2. Throughout her career, she has served on

27 Lymph is defined as fluid and cells, primarily lymphocytes, “collected from all parts of the 

body and returned to the blood via the lymphatic system.” Lymph, Dorland’s Med. Dictionary 

Online, https://www.dorlandsonline.com/dorland/definition?id=28971 (last visited May 27, 

2020).

introduction of the bacteria.” Id. Fourth, he asserts that bacteria were carried away from the 

point of introduction (vaccination) to a “possibly more susceptible area which has been 

traumatized” or has a “compromised blood flow.” Id.

In his third expert report, Dr. Latham provided a theory explaining how vaccination in the 

arm can cause necrotizing fasciitis in the hip. Pet. Ex. 24 at 1-2. Quoting the Merck Manual, he 

wrote “[i]noculation originates through the skin . . . and the defect may be surgical, trivial, 

distant from the disease site, or occult.” Id. at 1 (quoting Pet. Ex. 26 at 4). He gave examples of 

the mechanism. The first example is that dental care can cause endocarditis, due to bacteria in 

the mouth traveling through the blood stream to a compromised heart valve. Id. Another 

example was sepsis caused by an infection in the bladder or lungs. Id. The third example was 

lymphohematogenous27 spread of bacteria “from a distant source such as pneumonia or a remote 

wound infection.” Id. at 2. Dr. Latham stated that S. pyogenes is normally found in the skin and 

can also be harbored in the respiratory tract. Id. With regard to the facts here, he opined that the 

“injection of the vaccine caused the break in the skin which introduced the pathogenic organism 

into the bloodstream. This in turn, caused the necrotizing fasciitis.” Id. The bacteria “spread 

rapidly” once it entered the body. Id. It then infected the fascia, “connective bands of tissue that 

surround muscles, nerves, fat, and blood vessels.” Id. Dr. Latham described B.R.’s clinical 

course and how it was consistent with his proposed theory. Id. at 2-3. 

In his third and fourth reports, Dr. Latham addressed respondent’s assertions that B.R.’s 

necrotizing fasciitis was caused from either strep throat or vaginal infection. Pet. Ex. 24 at 3-4; 

Pet. Ex. 25 at 1-2. Dr. Latham opined that if B.R. had strep throat, she would have had a positive 

throat culture, and an “inflamed oropharynx.” Pet. Ex. 24 at 3; see also Pet. Ex. 25 at 2. He also 

disagreed that B.R.’s necrotizing fasciitis was caused by vaginal infection since urine cultures 

did not show streptococcal infection and there was no evidence of vaginal discharge. Pet. Ex. 24 

at 3. 
24

various committees and editorial boards and joined numerous professional societies. Resp. Ex.

AA at 3-5. Dr. Vargas has authored or co-authored almost 200 publications. Id. at 17-36. 

b. Opinion

i. Althen Prong One

Dr. Vargas does not disagree with Dr. Miller’s general theory of causation, but disagrees 

with his specific opinion that bacteria from a vaccination site can cause necrotizing fasciitis if 

there is no infection at the vaccination site. Tr. 189-90. Where the source of infection is the 

skin, Dr. Vargas does not believe that bacteria can proliferate and cause infection if the 

vaccination site is clean and without infection. Tr. 190. In the alternative, if the source of 

infection is from another area of the body that is colonized with strep, then an infection at the site 

is not required for the bacteria to travel to a distant site and cause infection. Tr. 193. 

Like Dr. Miller, Dr. Vargas testified that necrotizing fasciitis is “a rapidly moving 

bacterial infection involving deep soft tissue.” Tr. 128. She stated that in approximately fifty 

percent of cases, the source of the bacteria is not known. Tr. 128, 193-94. The infection that 

causes necrotizing fasciitis can come from sources other than skin. Tr. 128-29. Strep bacteria 

“can colonize surfaces that are contiguous with the outside world” like the throat and female 

genital tract. Tr. 128; see also Resp. Ex. Z at 1-2. Dr. Vargas opined that there can also be 

hematogenous translocation28 of strep “from the throat in the presence or absence of 

symptomatic pharyngitis to a site of blunt trauma or muscle strain.” Tr. 130 (quoting Resp. Ex. 

Z, Tab 2 at 5).

29

 

Dr. Vargas agreed that the skin can be the source of bacteria in necrotizing fasciitis. Tr. 

130. However, to attribute necrotizing fasciitis to a vaccine given at a distant site, Dr. Vargas

feels it would be important to see an infection at the point of entry or site of vaccination. Tr.

130-31. She agreed that vaccinations can introduce bacteria that cause necrotizing fasciitis, but

the bacteria can also come from somewhere else because there is no known source in over half of

the cases of necrotizing fasciitis. Tr. 133. Dr. Vargas also agreed that bacteria can travel to

distant sites. Tr. 135. She testified that bacteria can travel when large amounts of it are seeded

in the bloodstream. Id.

In support of her opinion that in order for vaccination to cause a distant site infection, 

there must first be an infection at the vaccination site, Dr. Vargas referenced the Cook article. 

Tr. 136-37; Resp. Ex. Z at 3. Dr. Vargas explained that in cases of infectious abscesses postvaccination, there is a description of an abscess or infection at the site of vaccine injection. Tr. 

28 Dr. Vargas defined translocation as the “way by which bacteria get into the bloodstream.” Tr. 

188.

29 Michael E. Pichichero, Complications of Streptococcal Tonsillopharyngitis, UpToDate, 

https://www.uptodate.com/contents/complications-of-streptococcal-tonsillopharyngitis (last 

updated Mar. 22, 2019).
25

30 The phrase “invasive infection” was used in an UpToDate article authored by Stevens and 

Kaplan and filed by respondent as Respondent’s Exhibit G. See Dennis L. Stevens & Sheldon L. 

Kaplan, Group A Streptococcal (Streptococcus Pyogenes) Bacteremia in Children, UpToDate, 

https://www.uptodate.com/contents/group-a-streptococcal-streptococcus-pyogenes-bacteremiain-children (last updated June 23, 2012). They define invasive infections to include “bacteremia, 

pneumonia, osteomyelitis, septic arthritis,” necrotizing fasciitis, “or any other infection 

associated with the isolation of [strep] from a normally sterile body site.” Resp. Ex. G at 1. 

31 After the hearing, respondent filed the Thomas article. Resp. Ex. BB. In it, the author states 

that the patient received a flu vaccine in the left upper arm. Id. at 1. One day later, she 

developed some discomfort at her vaccination site. Id. Other than the reference to discomfort, 

there is no description of infection or cellulitis at the site of vaccination. See id. at 1-2.

32 Joseph M. Bellapianta, Necrotizing Fasciitis, 17 J. Am. Acad. Orthopaedic Surgeons 174 

(2009).

33 Dennis L. Stevens & Larry M. Baddour, Necrotizing Soft Tissue Infections, UpToDate, 

https://www.uptodate.com/contents/necrotizing-soft-tissue-infections (last updated Feb. 28, 

2013).

138-40; see Resp. Ex. N. at 4-5 tbl.4. Dr. Vargas noted that she was “unable to find a single

reference in the medical literature in which any author ever attributed an invasive bacterial

infection to vaccination when there was no evident cellulitis occurring at the vaccination site

itself.”

30

 Resp. Ex. Z at 3; see also Tr. 147.

With regard to the necrotizing fasciitis cases summarized by Cook in Table 5, Dr. Vargas 

did not see “any evidence of any injection site that stayed clean and yet had an infection at a 

distant site attributed to it.” Tr. 144. There was one caveat: Dr. Vargas was unable to read the 

Thomas article listed in Table 5, and the description of that case study was too ambiguous for her 

to confirm that there was no infection at the site of vaccination.31 Tr. 144-45. 

In response to the Merck Manual reference cited by petitioner, Dr. Vargas testified that 

the examples used in that text were cases where an infection had “set up” and then the “infection 

travel[ed] to a distant site,” which is different than a situation where bacteria comes from “a 

clean site.” Tr. 146-47. 

Dr. Vargas cited several articles to support her opinions. In an article by Bellapianta, et 

al.,32 the authors state, “[n]ecrotizing fasciitis typically follows an injury to the involved site.” 

Resp. Ex. D at 1. The authors also state that “[n]ecrotizing fasciitis has been associated with . . . 

injection sites.” Id. “Although the skin is the most common portal of entry, in 45% of cases, no 

definitive access point can be found.” Id. at 2. One of the risk factors for the illness is obesity, 

although half of cases occur in healthy persons. Id. 

Another article cited by Dr. Vargas was a survey article by Stevens and Baddour.33 Resp. 

Ex. F. The authors state that strep “may localize to the exact site of muscle injury due to 
26

ii. Althen Prong Two

Dr. Vargas opined that in B.R.’s case, the bacteria that caused necrotizing fasciitis was 

introduced by a source other than vaccination. Tr. 168; Resp. Ex. A at 7. She stated that there is 

“no evidence that [B.R.’s] vaccination site . . . ever showed any evidence of infection” and “there 

is no known case of necrotizing fasciitis due to a medical injection in which the fasciitis occurred 

without involving the injected area.” Resp. Ex. M at 4. She further opined that “the more 

common and more probable causes of bacterial seeding of the groin fascia” include strep throat, 

“direct spread from a nearby genital infection,” and unknown or idiopathic. Resp. Ex. A at 8. 

She states that idiopathic cases are “well-known” but “poorly understood.” Id.

In her first expert report, Dr. Vargas opined strep throat was likely. Resp. Ex. A at 7. In 

her supplemental expert report, Dr. Vargas agreed with the testimony by Dr. Mills, when he 

“pointed to the throat as one of the possible sources of bacterial seeding.” Resp. Ex. M at 2. At 

34 Respondent cited an article by Varricchio et al., which explains that “VAERS are not formal 

case reports, but rather nonstandardized descriptions of symptoms and signs temporally 

associated with a vaccination or vaccinations. The information in a report is not necessarily 

complete, nor is it verified in most cases.” Frederick Varricchio et al., Understanding Vaccine 

Safety Information from the Vaccine Adverse Event Reporting System, 23 Pediatric Infectious 

Disease J. 287, 288 (2004) (filed as Resp. Ex. R). 

increased surface expression of the vimentin,” a protein, which binds the bacteria. Id. at 2. In 

cases with no clear entry point, the infection likely occurs due to hematogenous translocation of 

strep “from the throat (asymptomatic or symptomatic pharyngitis) to a site of blunt trauma or 

muscle strain.” Id. at 3. 

On cross-examination, Dr. Vargas agreed that strep can move through the body to remote 

locations from where it enters. Tr. 174-75. She also agreed that while strep is likely to be found 

in warm moist areas, it can be found anywhere on the body. Tr. 174. The bacteria “uses 

multiple tissues, including [] blood, to spread.” Tr. 175. Dr. Vargas specifically agreed that a 

puncture can introduce bacteria into the body. Id. 

When questioned about the septic arthritis cases summarized by Cook in Table 7, Dr. 

Vargas agreed that patients one, two, and four had infections at locations distant from 

vaccination. Tr. 178-79. She also agreed that Cook did not describe any infection at the site of 

injection in these three cases. Id. Dr. Vargas stated that the VAERS reports of these three cases 

were not filed, so there is no additional information about the site of injection.34 Tr. 193. 

Dr. Vargas testified that “septic arthritis is . . . just like necrotizing fasciitis, it presents, 

and we don’t know why. Many, many cases, we say it got there through the bloodstream, but we 

don’t know.” Tr. 183. In general, Dr. Vargas, explained that hematogenous is defined as 

“spread through the bloodstream.” Tr. 184. She testified that when there is no evidence of 

contiguous infection, or direct contamination, “then you have to invoke a hematogenous source.” 

Tr. 183. 
27

35 Ellen R. Wald, Approach to Diagnosis of Acute Infectious Pharyngitis in Children and 

Adolescents, UpToDate, http://www.uptodate.com/contents/approach-to-diagnosis-of-acuteinfectious-pharyngitis-inchildren-and-adolescents (last updated June 2, 2015). 

the hearing, Dr. Vargas testified that the medical records state that B.R. had a sore throat and 

“mildly injected” throat, which supports her opinion that the strep bacteria could have come from 

the throat. Tr. 154-57. Dr. Vargas asserts that B.R.’s sore throat had occurred “off and on for a 

week” prior to her transfer to Phoebe Putney on April 3, and thus, it preceded her vaccination. 

Resp. Ex. Z at 2. 

According to Dr. Vargas, B.R.’s negative rapid strep test and negative throat culture do 

not “rule out” the possibility of S. pyogenes in the throat. Resp. Ex. M at 5. She notes that 

“throat cultures are known to miss 5-10% of S. pyogenes infection[s].” Id. When asked about 

the accuracy of the rapid strep test and throat culture, Dr. Vargas agreed with Dr. Miller’s 

testimony that the tests were 90% accurate, stating Dr. Miller was “not too far off.” Tr. 171. 

Respondent filed a medical article by Wald35 which confirmed the veracity of Dr. Miller’s 

opinion. Resp. Ex. M, Tab 7 at 5. Wald observes that “[w]hen performed properly, the 

sensitivity of [a] throat culture is 90 to 95 percent for [group A strep].” Id.

The reference in B.R.’s medical record to a rash was significant to Dr. Vargas. She 

testified that “a rash is a common manifestation of strep pyogenes infection.” Tr. 156. She 

noted the records indicate on April 4 that a rash had been present off and on for three days. 

Resp. Ex. Z at 3 (citing Pet. Ex. 14 at 28, 59). Dr. Vargas opined that rashes in patients with 

strep throat are often seen one to two days after the onset of bacterial infection. Id. She stated 

that “[t]he characteristic rash occurring in the setting of group A strep infection is termed scarlet 

fever.” Id. She further opined that in patients with scarlet fever, the most common site for 

bloodstream infection (sepsis) is the pharynx (throat). Id. 

On cross-examination, Dr. Vargas was questioned about B.R.’s medical record entries 

related to the presence of a rash on physical examination. On March 31 and April 1, no rash was 

noted on examination. Pet. Ex. 14 at 3-4, 10-12. On April 3, Dr. Kocherla noted a rash on 

B.R.’s neck. Pet. Ex. 13 at 17; Resp. Ex. X at 40. Dr. Vargas agreed that if the infection started

in B.R.’s leg on April 1, then one could attribute a rash present on April 2 or 3 to the infection in

B.R.’s leg. Tr. 174.

Next, Dr. Vargas testified about the autopsy, specifically her review of one microscopic 

slide of lung tissue. She opined that lung tissue slide Q showed inflammatory cells and intra 

alveolar macrophages. Tr. 160-63. Dr. Vargas described an area with “mucopurulent material in 

alveolar spaces.” Tr. 163. She explained that these findings indicated “possible early 

bronchopneumonia.” Resp. Ex. M at 2; see also Resp. Ex. Z at 3-4. Dr. Vargas stated these 

findings “fit[] very well with bacteria coming down from the upper respiratory tract, down into 

the lungs.” Tr. 164. However, she explained that it “doesn’t have to be strep” that caused the

finding seen in the lung slide; “[o]ther bacteria could have done this, but it fits, you know, that it 

could have been strep.” Id. Dr. Vargas conceded that the finding on the lung slide was not 

unique to, or diagnostic of, strep throat. Tr. 185. 
28

iii. Althen Prong Three

Dr. Vargas testified that a 14 hour onset seemed too short a period of time for transient 

bacteremia to occur from a vaccine injection, and for the bacteria to travel to a distant site and

multiply. Tr. 190-91. Dr. Vargas opined that onset would not “be less than 24 hours.” Tr. 190.

She did not cite any source to support her onset opinion. 

Respondent filed several articles addressing onset. In Stevens, the authors studied 20 

cases of Group A Streptococcal soft tissue infection. Resp. Ex. Z, Tab 4 at 2. One patient had 

36 Dr. Vargas testified that she did not review the actual chest X-ray, only the report. Tr. 186.

More importantly, Dr. Vargas conceded that the findings were “very common in any 

death, any hospital death that [she] see[s].” Tr. 185. Dr. Vargas testified that it is common for 

patients to get pneumonia when they are very ill. Id. Further, she stated that when patients get 

septic, it is “common to start getting the proteinaceous exudate into the lung. It’s the lung’s way 

of reacting.” Id.

In addition to the lung tissue slide, Dr. Vargas believes that B.R.’s chest X-ray36 showed 

“opacities in the lung fields,” that looked like “very early bronchopneumonia.” Tr. 165. She 

testified that there was no “frank” or “obvious pneumonia” but they could not “exclude 

bronchitis or an atypical pneumonia.” Tr. 188. Based on the chest X-ray, Dr. Vargas believes 

the changes she saw in lung tissue occurred before B.R. became critically ill. Tr. 186. She 

explained that portable chest X-rays, like the one here, are more difficult to interpret than 

standard chest X-rays with two views. Tr. 188. Dr. Vargas said that the radiologist saw a “slight 

prominence of the interstitial markings in the infrahilar regions,” which she interpreted as 

“bronchitis and an early bronchopneumonia.” Tr. 187. However, the radiologist who interpreted 

B.R.’s portable chest X-ray stated, “No evidence of frank pneumonia. Cannot exclude bronchitis

or atypical pneumonia.” Pet. Ex. 13 at 27. The radiologist did not diagnosis B.R. with

bronchitis or early bronchopneumonia. See id.

Dr. Vargas filed a several articles that specifically support her opinion that the source of 

B.R.’s strep infection was the throat, including the Stevens and Baddour article. See Resp. Ex.

F. The authors state that “[i]n cases with no clear portal of entry, the pathogenesis of infection

likely consists of hematogenous translocation of [Group A Streptococcus] from the throat . . . to

a site of blunt trauma or muscle strain.” Id. at 3.

In the UpToDate article by Stevens and Kaplan, the authors agreed that “among patients 

with scarlet fever, the pharynx is the most common source of bloodstream [Group A 

Streptococcus].” Resp. Ex. G at 3. However, they noted that “[t]he least common source of 

bacteremia in children has been the lower respiratory tract. When bacteremic [Group A 

Streptococcal] pneumonia occurs, it usually is associated with prior viral infections, particularly 

influenza.” Id. They also state that “[t]he most frequent source of [Group A Streptococcal] 

bacteremia in children is the skin,” incited by cellulitis, minor trauma, and varicella infections. 

Id. at 2. 
29

IV. DISCUSSION

A. Standards for Adjudication

The Vaccine Act was established to compensate vaccine-related injuries and deaths. 

§ 10(a). “Congress designed the Vaccine Program to supplement the state law civil tort system

as a simple, fair and expeditious means for compensating vaccine-related injured persons. The

Program was established to award ‘vaccine-injured persons quickly, easily, and with certainty

and generosity.’” Rooks v. Sec’y of Health & Human Servs., 35 Fed. Cl. 1, 7 (1996) (quoting

H.R. Rep. No. 908 at 3, reprinted in 1986 U.S.C.C.A.N. at 6287, 6344).

Petitioner’s burden of proof is by a preponderance of the evidence. § 13(a)(1). The 

preponderance standard requires a petitioner to demonstrate that it is more likely than not that the 

vaccine at issue caused the injury. Moberly v. Sec’y of Health & Human Servs., 592 F.3d 1315, 

1322 n.2 (Fed. Cir. 2010). Proof of medical certainty is not required. Bunting v. Sec’y of Health 

& Human Servs., 931 F.2d 867, 873 (Fed. Cir. 1991). In particular, petitioner must prove that 

the vaccine was “not only [the] but-for cause of the injury but also a substantial factor in 

bringing about the injury.” Moberly, 592 F.3d at 1321 (quoting Shyface v. Sec’y of Health & 

Human Servs., 165 F.3d 1344, 1352-53 (Fed. Cir. 1999)); see also Pafford v. Sec’y of Health & 

Human Servs., 451 F.3d 1352, 1355 (Fed. Cir. 2006). A petitioner who satisfies this burden is 

entitled to compensation unless respondent can prove, by a preponderance of the evidence, that 

37 Rajoo Thapa et al., Necrotizing Fasciitis Following BCG Vaccination, 48 Indian Pediatrics 

235 (2011).

38 BCG stands for “Bacille-Calmette-Guérin.” Resp. Ex. H at 1. BCG is a vaccine for 

tuberculosis. Tuberculosis (TB): BCG Vaccine Fact Sheet, Ctrs. for Disease Control & 

Prevention, https://www.cdc.gov/tb/publications/factsheets/prevention/bcg.htm (last reviewed 

May 4, 2016).

39 Tang Chi Thuong et al., An Outbreak of Severe Infections with Community-Acquired MRSA 

Carrying the Panton-Valentine Leukocidin Following Vaccination, 2 PLoS ONE e822 (2007).

40 The vaccines included Hepatitis B (“HBV”), Measles, Mumps, Rubella (“MMR”), and 

varicella. Resp. Ex. O at 3. 

“fulminant myositis eight hours after presentation.” Id. In Thapa et al.,37 the authors presented a 

case report of an infant who developed necrotizing fasciitis following a BCG38 vaccination. 

Resp. Ex. H at 1. The infant had symptoms of infection 18 hours after vaccination. Id.

The authors of Thuong, et al.39

 summarize data of nine children who developed severe 

Staphylococcus aureus infections following vaccination.40 Resp. Ex. O at. 1. Three children had 

a systemic syndrome consistent with toxic shock syndrome. Id. at 2. Four of the children had 

skin and soft tissue infections, including one with necrotizing fasciitis. Id. All of the skin and 

soft tissue infections occurred at the vaccination site. Id. In seven of the nine children, onset of 

symptoms occurred in a range of nine to 14 hours. Id. at 3. 
30

the vaccinee’s injury is “due to factors unrelated to the administration of the vaccine.” §

13(a)(1)(B).

B. Factual Issues

A petitioner must prove, by a preponderance of the evidence, the factual circumstances 

surrounding her claim. § 13(a)(1)(A). To resolve factual issues, the special master must weigh 

the evidence presented, which may include contemporaneous medical records and testimony. 

See Burns v. Sec’y of Health & Human Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (explaining that 

a special master must decide what weight to give evidence including oral testimony and 

contemporaneous medical records). Contemporaneous medical records are presumed to be 

accurate. See Cucuras v. Sec’y of Health & Human Servs., 993 F.2d 1525, 1528 (Fed. Cir. 

1993). To overcome the presumptive accuracy of medical records, a petitioner may present 

testimony which is “consistent, clear, cogent, and compelling.” Sanchez v. Sec’y of Health & 

Human Servs., No. 11–685V, 2013 WL 1880825, at *3 (Fed. Cl. Spec. Mstr. Apr. 10, 2013) 

(citing Blutstein v. Sec’y of Health & Human Servs., No. 90–2808V, 1998 WL 408611, at *5 

(Fed. Cl. Spec. Mstr. June 30, 1998)).

There are situations in which compelling testimony may be more persuasive than written 

records, such as where records are deemed to be incomplete or inaccurate. Campbell v. Sec’y of 

Health & Human Servs., 69 Fed. Cl. 775, 779 (2006) (“[L]ike any norm based upon common 

sense and experience, this rule should not be treated as an absolute and must yield where the 

factual predicates for its application are weak or lacking.”); Lowrie v. Sec’y of Health & Human 

Servs., No. 03–1585V, 2005 WL 6117475, at *19 (Fed. Cl. Spec. Mstr. Dec. 12, 2005) 

(“[W]ritten records which are, themselves, inconsistent, should be accorded less deference than 

those which are internally consistent.” (quoting Murphy v. Sec’y of Health & Human Servs., 23 

Cl. Ct. 726, 733 (1991), aff’d per curiam, 968 F.2d 1226 (Fed. Cir. 1992))). Ultimately, a 

determination regarding a witness’s credibility is needed when determining the weight that such 

testimony should be afforded. Andreu v. Sec’y of Health & Human Servs., 569 F.3d 1367, 1379 

(Fed. Cir. 2009); Bradley v. Sec’y of Health & Human Servs., 991 F.2d 1570, 1575 (Fed. Cir. 

1993).

Despite the weight afforded medical records, special masters are not bound rigidly by 

those records in determining onset of a petitioner’s symptoms. Valenzuela v. Sec’y of Health & 

Human Servs., No. 90–1002V, 1991 WL 182241, at *3 (Fed. Cl. Spec. Mstr. Aug. 30, 1991); see 

also Eng v. Sec’y of Health & Human Servs., No. 90–1754V, 1994 WL 67704, at *3 (Fed. Cl. 

Spec. Mstr. Feb. 18, 1994) (Section 13(b)(2) “must be construed so as to give effect also to § 

13(b)(1) which directs the special master or court to consider the medical records (reports, 

diagnosis, conclusions, medical judgment, test reports, etc.), but does not require the special

master or court to be bound by them”).

C. Causation

To receive compensation through the Program, petitioner must prove either (1) that B.R. 

suffered a “Table Injury”—i.e., an injury listed on the Vaccine Injury Table—corresponding to a 

vaccine that she received, or (2) that B.R. suffered an injury that was actually caused by a 
31

D. Causation Analysis

1. Althen Prong One

Under Althen Prong One, petitioner must set forth a medical theory explaining how the 

received vaccine could have caused the sustained injury. Andreu, 569 F.3d at 1375; Pafford, 451 

vaccination. See §§ 11(c)(1), 13(a)(1)(A); Capizzano v. Sec’y of Health & Human Servs., 440 

F.3d 1317, 1319-20 (Fed. Cir. 2006). Because petitioner does not allege that B.R. suffered a

Table Injury, she must prove that a vaccine B.R. received caused her injury. To do so, she must

establish, by preponderant evidence: (1) a medical theory causally connecting the vaccine and

B.R.’s injury (“Althen Prong One”); (2) a logical sequence of cause and effect showing that the

vaccine was the reason for B.R.’s injury (“Althen Prong Two”); and (3) a showing of a

proximate temporal relationship between the vaccine and B.R.’s injury (“Althen Prong Three”).

§ 13(a)(1); Althen, 418 F.3d at 1278.

The causation theory must relate to the injury alleged. The petitioner must provide a 

sound and reliable medical or scientific explanation that pertains specifically to this case, 

although the explanation need only be “legally probable, not medically or scientifically certain.” 

Knudsen v. Sec’y of Health & Human Servs., 35 F.3d 543, 548-49 (Fed. Cir. 1994). Petitioner 

cannot establish entitlement to compensation based solely on her assertions; rather, a vaccine 

claim must be supported either by medical records or by the opinion of a medical doctor. § 

13(a)(1). In determining whether petitioner is entitled to compensation, the special master shall 

consider all material in the record, including “any . . . conclusion, [or] medical judgment . . .

which is contained in the record regarding . . . causation.” § 13(b)(1)(A). The undersigned must 

weigh the submitted evidence and the testimony of the parties’ proffered experts and rule in 

petitioner’s favor when the evidence weighs in her favor. See Moberly, 592 F.3d at 1325-26 

(“Finders of fact are entitled—indeed, expected—to make determinations as to the reliability of 

the evidence presented to them and, if appropriate, as to the credibility of the persons presenting 

that evidence.”); Althen, 418 F.3d at 1280 (noting that “close calls” are resolved in petitioner’s 

favor). 

“Expert medical testimony which merely expresses the possibility—not the probability—

of the occurrence of a compensable injury is insufficient, by itself, to substantiate the claim that 

such an injury occurred.” LaCour v. Sec’y of Health & Human Servs., No. 90–316V, 1991 WL 

66579, at *5 (Fed. Cl. Spec. Mstr. Apr. 15, 1991); accord Burns v. Sec’y of Health & Human 

Servs., No. 90–953V, 1992 WL 365410, at *6 (Fed. Cl. Spec. Mstr. Nov. 6, 1992), aff’d, 3 F.3d 

415 (Fed. Cir. 1993). The Federal Circuit has likewise made clear that the mere possibility of a 

link between a vaccination and a petitioner’s injury is not sufficient to satisfy the preponderance 

standard. Moberly, 592 F.3d at 1322 (emphasizing that “proof of a ‘plausible’ or ‘possible’ 

causal link between the vaccine and the injury” does not equate to proof of causation by a 

preponderance of the evidence); Waterman v. Sec’y of Health & Human Servs., 123 Fed. Cl. 

564, 573-74 (2015) (denying petitioner’s motion for review and noting that a possible causal link 

was not sufficient to meet the preponderance standard). While certainty is by no means required, 

a possible mechanism does not rise to the level of preponderance. Id.; see also De Bazan v. 

Sec’y of Health & Human Servs., 539 F.3d 1347, 1351 (Fed. Cir. 2008). 
32

F.3d at 1355-56. Petitioner’s theory of causation need not be medically or scientifically certain,

but it must be informed by a “sound and reliable” medical or scientific explanation. Boatmon v.

Sec’y of Health & Human Servs., 941 F.3d 1351, 1359 (Fed. Cir. 2019); see also Knudsen, 35

F.3d at 548; Veryzer v. Sec’y of Health & Human Servs., 98 Fed. Cl. 214, 223 (2011) (noting

that special masters are bound by both § 13(b)(1) and Vaccine Rule 8(b)(1) to consider only

evidence that is both “relevant” and “reliable”). If petitioner relies upon a medical opinion to

support her theory, the basis for the opinion and the reliability of that basis must be considered in

the determination of how much weight to afford the offered opinion. See Broekelschen v. Sec’y

of Health & Human Servs., 618 F.3d 1339, 1347 (Fed. Cir. 2010) (“The special master’s

decision often times is based on the credibility of the experts and the relative persuasiveness of

their competing theories.”); Perreira v. Sec’y of Health & Human Servs., 33 F.3d 1375, 1377 n.6

(Fed. Cir. 1994) (stating that an “expert opinion is no better than the soundness of the reasons

supporting it” (citing Fehrs v. United States, 620 F.2d 255, 265 (Ct. Cl. 1980))).

Petitioner cannot prevail with just an opinion that since there is no other factor to explain 

B.R.’s infection but the vaccines, the vaccines must have been the cause. However, this case

involves more than that assertion. Both Dr. Miller and Dr. Vargas, as well as Cook and other

authors of the medical literature filed in this matter, agree that there is streptococcal bacteria on

the skin. They agree that an injection can serve as a portal of entry for the bacteria to enter the

tissues and blood stream. They agree that this mechanism of action—hematogenous spread

through the blood stream—can cause sepsis and other rare, adverse, and even fatal, infections.

They agree that these invasive infections can occur in sites distant to the portal of entry. For

example, in osteomyelitis, the infection occurs in the bone. In septic arthritis, the infection

occurs in the joint. In the case of endophthalmitis, the infection occurs in the eye. This causal

mechanism, recognized by the experts and authors of relevant medical literature, is thus, sound

and reliable.

Respondent, however, adds an additional requirement to the causal mechanism as it 

relates to the facts and circumstances presented here. Respondent argues that a patient must have 

an infection at the portal of entry—here, the site of vaccination—in order for there to be spread 

of that bacteria by the bloodstream to a remote site. None of the medical articles filed by either 

party address that narrow issue. The articles provide a brief summary of the facts about each 

case report. Some of the articles describe the local condition of the skin where the portal of entry 

is the skin. The take away from the medical literature relevant here is that injections, including 

vaccinations given by injection penetrating the skin, can provide a portal of entry for bacteria to 

spread via the bloodstream to other sites. 

Dr. Vargas agreed that the mechanism of hematogenous spread is the same for septic 

arthritis as it is for necrotizing fasciitis. Likewise, Cook did not draw distinctions in the 

mechanism of hematogenous bacterial spread, as applied to septic arthritis, osteomyelitis, or 

necrotizing fasciitis. Certainly, the case reports specific to necrotizing fasciitis occurring after 

vaccination may have included information suggesting there may have been signs of infection at 

the site of vaccination or injection. However, this was not universal. Further, the case reports of 

invasive infections caused by strep bacteria, including bacteremia, osteomyelitis, and septic 

arthritis, often omitted a description of the vaccine or infection site. None of the authors of the 

relevant articles stated an opinion like that held by Dr. Vargas, specifically that there must be 
33

infection at the vaccine site for a remote infection to occur. Thus, it would be erroneous for the 

undersigned to impose the equivalent of a “condition precedent” to a causal mechanism where 

physicians who have studied and authored medical reports on the subject did not do so. 

Accordingly, the undersigned finds that petitioner has set forth a sound and reliable medical 

theory, satisfying Althen Prong One.

2. Althen Prong Two

Under Althen Prong Two, petitioner must prove by a preponderance of the evidence that 

there is a “logical sequence of cause and effect showing that the vaccination was the reason for 

the injury.” Capizzano, 440 F.3d at 1324 (quoting Althen, 418 F.3d at 1278). “Petitioner must 

show that the vaccine was the ‘but for’ cause of the harm . . . or in other words, that the vaccine 

was the ‘reason for the injury.’” Pafford, 451 F.3d at 1356 (internal citations omitted). 

In evaluating whether this prong is satisfied, the opinions and views of the vaccinee’s 

treating physicians are entitled to some weight. Andreu, 569 F.3d at 1367; Capizzano, 440 F.3d 

at 1326 (“[M]edical records and medical opinion testimony are favored in vaccine cases, as 

treating physicians are likely to be in the best position to determine whether a ‘logical sequence 

of cause and effect show[s] that the vaccination was the reason for the injury.’” (quoting Althen, 

418 F.3d at 1280)). Medical records are generally viewed as trustworthy evidence, since they are 

created contemporaneously with the treatment of the vaccinee. Cucuras, 993 F.2d at 1528. The 

petitioner need not make a specific type of evidentiary showing, i.e., “epidemiologic studies, 

rechallenge, the presence of pathological markers or genetic predisposition, or general 

acceptance in the scientific or medical communities to establish a logical sequence of cause and 

effect.” Capizzano, 440 F.3d at 1325. Instead, petitioner may satisfy her burden by presenting 

circumstantial evidence and reliable medical opinions. Id. at 1325-26.

Petitioner has demonstrated that administration of vaccines can lead to remote site 

infections, including necrotizing fasciitis and septic shock, through hematogenous spread of 

bacteria and thus, satisfied Althen Prong One. Petitioner has also shown causation specific to 

this case—that B.R.’s vaccinations lead to her necrotizing fasciitis and septic shock, 

consequently causing her death. There is preponderant evidence to establish a “logical sequence 

of cause and effect showing that the vaccination was the reason for the injury.” Capizzano, 440 

F.3d at 1324 (quoting Althen, 418 F.3d at 1278).

There are three reasons for this finding. First, B.R.’s clinical course and autopsy are

consistent with the mechanism proposed by Dr. Miller. Second, there is insufficient evidence to 

support a finding that B.R. had strep throat, early pneumonia, or a urogenital source of infection. 

And third, this finding is consistent with the medical records and testimony of treating 

physicians, Dr. Kocherla and Dr. Darden, and pathologist, Dr. Latham. 

a. Clinical Course and Autopsy

B.R. was healthy, although mildly obese, on the day that she received four vaccinations 

by injection—four needle punctures of the skin. Within 15 hours, she had left hip pain and fever. 

A throat culture was negative for strep, but a blood culture revealed strep in her blood. She 
34

B.R.’s course. Twelve of the 20 patients had bacteremia, and of these patients, six died. Id. at 4.

Of these six, three died within 36 hours of hospital admission. Id. Nineteen patients had shock

on admission to the hospital or shortly thereafter. Id.

b. B.R. Did Not Have Strep Throat, Pneumonia, or a Urogenital

Source of Infection

Based on the medical records, results of the throat culture, autopsies, expert reports and 

testimony, and the totality of facts and circumstances, the undersigned finds that B.R. did not 

have strep throat, pneumonia, or a urogenital source of infection that caused her necrotizing 

fasciitis and septic shock. 

While the records include a reference to sore throat and a description that B.R.’s throat 

was “mildly injected,” this evidence is insufficient to establish that B.R. had strep throat given 

the weight of the evidence against such a finding. The most compelling evidence was B.R.’s 

negative throat culture. When performed properly, the literature and experts agreed that this test

has an accuracy rate of 90-95%. See Tr. 32, 71, 171. There is no evidence that B.R.’s throat 

culture was performed improperly. The negative results establish that it is very unlikely that she 

had strep throat or that the bacteria that seeded her necrotizing fasciitis came from the throat. 

The consecutive physical examinations of B.R. conducted by different doctors over a 

five-day period provide more evidence that B.R. did not have strep throat. The physicians who 

performed these exams did not document evidence of the usual characteristics of strep throat, 

which include inflamed appearance, often with white follicles or exudate. B.R. did not have 

adenopathy or enlarged lymph nodes in the neck area suggestive of a throat infection. None of 

B.R.’s treating physicians diagnosed her with strep throat. Additionally, the two pathologists

who performed autopsies did not attribute her infection to strep throat.

developed septicemia and septic shock, which caused her death. There is no evidence that she 

had a genital infection. The autopsies did not show any source for the bacteria. For these 

reasons, Dr. Miller concluded that bacteria was introduced into the bloodstream by a vaccination, 

“a rare but reported complication” of vaccination administered by needle injection. Pet. Ex. 43 

at 8; see also Tr. 96-97. 

Through the expert report and testimony of Dr. Miller, petitioner established by 

preponderant evidence that B.R. developed transient bacteremia—that is, bacteria entered the 

bloodstream from vaccination, which seeded the soft tissue of the hip and thigh. The autopsy 

established that B.R. had S. pyogenes, a bacteria known to be present on the skin and a known 

cause of infection. The autopsy findings were consistent with septic shock and an infection in 

tissue of the left thigh and hip. B.R. developed necrotizing fasciitis, infection of the 

bloodstream, and septic shock which caused her death. 

Moreover, B.R.’s clinical course was consistent with the case reports in the medical 

literature filed in this case. In Stevens, the authors studied 20 cases of Group A Streptococcal

soft tissue infection. Resp. Ex. Z, Tab 4 at 1. Abrupt onset with severe pain was the common 

presentation. Id. at 2. One patient had “fulminant myositis eight hours after presentation.” Id. 

In addition to onset, the clinical course of several of the patients was similar in time frame to 
35

There is also insufficient evidence to support respondent’s position that B.R. may have 

had early pneumonia or bronchopneumonia. There is no documentation that B.R. had a cough, 

wheezing, or respiratory distress, and until she became critically ill on April 4, she had no 

respiratory distress. Medical records establish that on her admission to Phoebe Putney on April 

3, B.R. had no history of cough, wheezing, trouble breathing, or respiratory distress. Lung 

sounds were clear bilaterally. B.R. was not diagnosed with pneumonia by any of the doctors 

who examined her on March 31, April 1, April 3, or April 4. The two pathologists who 

performed autopsies also did not diagnose pneumonia. 

Dr. Vargas opined that one lung tissue slide (slide Q) may have shown findings that 

indicated “possible early bronchopneumonia.” Resp. Ex. M at 2; see also Resp. Ex. Z at 3-4. 

However, opinions based on possibilities are insufficient to establish causation. See, e.g., 

Moberly, 592 F.3d at 1322; De Bazan, 539 F.3d at 1351; Burns, 1992 WL 365410, at *6; 

LaCour, 1991 WL 66579, at *5. 

Further, Dr. Vargas conceded that the findings on lung slide Q, are “very common in . . . 

any hospital death,” as it is common for patients to get pneumonia where they are very ill. Tr. 

185. Assuming this was true for B.R., if she did have pneumonia, it would have occurred after

she became very ill on April 4, and therefore, it would not have caused the infection that

manifested as hip pain on April 1.

With regard to Dr. Vargas’ opinion that B.R.’s chest X-ray showed very early 

bronchopneumonia, that opinion was based, in part, on her review and opinion of one lung slide. 

For the reasons explained above, the undersigned does not find Dr. Vargas’ opinion about the 

lung slide to be persuasive evidence that B.R.’s infection was caused by pneumonia. Moreover, 

the undersigned finds the opinion of the interpreting radiologist to be the most reliable evidence 

as to the results of the X-ray, and that opinion did not include the finding of pneumonia. 

Lastly, there is no evidence to support a conclusion that B.R.’s infection originated from 

a urogenital source. The medical records do not document that B.R. ever complained of 

urogenital symptoms. Her urinalysis was normal. Her urine culture did not show bacterial 

infection. B.R. was not diagnosed with urogenital infection by any treating physician. On 

autopsy, external genitalia was unremarkable and there was no inguinal lymphadenopathy. The 

pathologists did not make any findings consistent with urogenital infection, or attribute B.R.’s 

infection to a urogenital source. 

In summary, there is either no evidence or insufficient evidence to show that the source 

of B.R.’s infection was due to any source other than her vaccinations. As to Dr. Vargas’ position

that the cause was idiopathic or unknown, that might be a viable option but for the fact that B.R. 

had four injections of her skin, and the breach of the skin, even when the skin is properly 

cleaned, is known to be associated with remote infections, caused by hematogenous spread. The 

undersigned cannot ignore the fact of B.R.’s vaccinations, and the resulting portal of entry that 

each injection created, so as to entertain a suggestion that they did not play a role, and thus 

conclude that the cause here was idiopathic. 
36

c. Treating Physicians41

Several of B.R.’s treating physicians records offered evidence supportive of vaccine 

causation. On April 3, Dr. Kocherla’s diagnosis was post-vaccination reaction. He ordered a 

sepsis workup, including blood cultures that revealed S. pyogenes. In his deposition, Dr. 

Kocherla testified that he believed that B.R. had sepsis or post-vaccination myopathy, and he

was correct. The blood cultures revealed that B.R. had S. pyogenes sepsis. 

Orthopedist Dr. Darden examined B.R. after her transfer to Phoebe Putney. His 

impression was transient synovitis secondary to viral load from vaccines and possible bacterial 

sepsis of the joint. Testing of the joint was not performed, so it is not known whether B.R. had a 

septic joint. Regardless, based on the literature filed in this case, a septic joint caused by bacteria

occurs due to the same mechanism of action propounded by Dr. Miller. 

The pathologists were split on the issue of vaccine causation. In his autopsy, Dr. Burns 

did not express an opinion as to vaccine causation, but in his deposition, he testified that B.R.’s 

vaccinations had nothing to do with her illness. On the other hand, Dr. Latham opined that the 

vaccines may have caused B.R.’s illness based on the fact that she had S. pyogenes, which is 

known to be present on the body, and that the illness can be caused by a skin prick, or in this 

case vaccination. 

On the whole, the undersigned finds the records and opinions of Drs. Kocherla, Darden, 

and Latham provide support for vaccine causation, and when combined with the other evidence 

summarized above, add to the weight of the evidence in favor of petitioner. 

The undersigned found petitioner’s Althen Prong One theory sound and reliable, and now 

finds petitioner, by preponderant evidence, has shown that the vaccinations were the source of 

the bacteria that caused B. R.’s infection and death. Accordingly, petitioner has satisfied Althen

Prong Two.

3. Althen Prong Three

Althen Prong Three requires petitioner to establish a “proximate temporal relationship” 

between the vaccination and the injury alleged. Althen, 418 F.3d at 1281. That term has been 

equated to mean a “medically acceptable temporal relationship.” Id. The petitioner must offer 

“preponderant proof that the onset of symptoms occurred within a timeframe which, given the 

medical understanding of the disease’s etiology, it is medically acceptable to infer causation-infact.” De Bazan, 539 F.3d at 1352. The explanation for what is a medically acceptable time 

frame must also coincide with the theory of how the relevant vaccine can cause the injury alleged 

(under Althen Prong One). Id.; Koehn v. Sec’y of Health & Human Servs., 773 F.3d 1239, 1243 

41 The undersigned has considered the opinions and testimony of all of the physicians whose 

depositions were filed in this matter but gives more weight to the opinions and testimony of 

those who treated B.R. and created contemporaneous medical records. Thus, the opinion of Dr. 

Mills, who was not a treating physician nor an expert in this matter, was afforded less weight.
37

(Fed. Cir. 2014); Shapiro v. Sec’y of Health & Human Servs., 101 Fed. Cl. 532, 542 (2011), 

recons. den’d after remand, 105 Fed. Cl. 353 (2012), aff’d mem., 503 F. App’x 952 (Fed. Cir. 

2013).

The undersigned finds petitioner has provided preponderant evidence of a proximate

temporal relationship between B.R.’s vaccinations and the first manifestation of the infection 

which led to her death. Dr. Miller and Dr. Vargas agree that the time frame between B.R.’s 

vaccinations and the onset of her infection, marked by hip and thigh pain, was approximately 14 

hours. Dr. Miller opined that 14 hours was appropriate, and cited to the case report published by 

Stevens. Dr. Vargas testified that 14 hours seemed too short, but did not cite any literature or 

other evidence to support her testimony on this point. The articles cited by respondent provided 

eight cases where onset was in the range of nine to 18 hours. See Resp. Ex. H at 1 (discussing 

patient with symptoms of infection 18 hours post-vaccination); Resp. Ex. O at 3 (describing

seven children who had onset ranging from nine to 14 hours). Given the case reports described 

in the literature, and the lack of other evidence, the undersigned finds the petitioner’s evidence as 

to onset more credible and persuasive.

E. Alternative Causation

Because the undersigned concludes that petitioner has established a prima facie case, 

petitioner is entitled to compensation unless respondent can put forth preponderant evidence 

“that [B.R.’s] injury was in fact caused by factors unrelated to the vaccine.” Whitecotton v. 

Sec’y of Health & Human Servs., 17 F.3d 374 (Fed. Cir. 1994), rev’d on other grounds sub 

nom., Shalala v. Whitecotton, 514 U.S. 268 (1995); see also Walther v. Sec’y of Health & 

Human Servs., 485 F.3d 1146, 1151 (Fed. Cir. 2007). As discussed above in the analysis related 

to Althen Prong Two, the undersigned found the respondent failed to establish evidence to show 

that B.R.’s infection was caused by a source other than her vaccinations. Thus, respondent did 

not prove by a preponderance of evidence that B.R.’s injury is “due to factors unrelated to the 

administration of the vaccine.” § 13(a)(1)(B).

V. CONCLUSION

This is a very tragic case. The undersigned extends her sympathy to the petitioner and

family of B.R. for their loss. The undersigned’s decision, however, is not based on sympathy, 

but based on the evidence. For the reasons discussed above, the undersigned finds that 

petitioner has established by preponderant evidence that she is entitled to compensation. A 

separate damages order will issue.

IT IS SO ORDERED.

s/Nora Beth Dorsey

 Nora Beth Dorsey

 Special Master